{"study_id": 190112, "supplement_id": 1209, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to determine the frequency and reasons for using honey as a complementary and alternative medicine (CAM) among children with cancer and its impact on long-term survival.", "results_summary": "Honey was one of the most commonly used biologically based CAM therapies (43.2%) among children with cancer, typically as a complement to conventional treatment. The study found no statistically significant effect of CAM use, including honey, on long-term survival rates (81.5% for CAM users vs. 86.5% for nonusers).", "population_specificity": "Children with cancer aged 0-18 years (50 girls, 70 boys).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:13.448320+00:00"}
{"study_id": 190117, "supplement_id": 1209, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the effect of honey on gastric emptying time (GET) during nutritional rehabilitation of patients with protein-energy malnutrition (PEM).", "results_summary": "Honey supplementation significantly delayed GET in PEM patients compared to conventional therapy, while also showing a non-significantly higher rate of improvement in anthropometric measurements and serum albumin levels. The delay in GET was suggested as a potential compensatory mechanism enhanced by honey.", "population_specificity": "Patients with protein-energy malnutrition (PEM).", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:14.053033+00:00"}
{"study_id": 190116, "supplement_id": 1209, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of honey on complement hemolytic activity (CH50) in patients with protein energy malnutrition (PEM).", "results_summary": "Honey supplementation significantly increased CH50 levels in PEM patients compared to placebo, though it did not significantly improve anthropometric measures or serum albumin. The study suggests honey may enhance immune function in PEM patients, but its impact on infection frequency and severity requires further investigation.", "population_specificity": "Thirty infants with protein energy malnutrition (PEM) and 20 healthy infants as controls.", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:14.192687+00:00"}
{"study_id": 17085, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Hordenine's role and mechanism in mitigating LPS-induced inflammatory responses in mouse mammary epithelial cells and a mouse mastitis model.", "results_summary": "Hordenine reduced LPS-induced mammary tissue damage, restored blood-milk barrier integrity, inhibited TLR4-MAPK/NF-\u03baB signaling, activated AMPK/Nrf2/HO-1 signaling, and altered intestinal microbiota composition to reduce inflammatory injury.", "population_specificity": "Mouse mammary epithelial cells (EpH4-Ev) and a mouse mastitis model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:14.793486+00:00"}
{"study_id": 190114, "supplement_id": 1209, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether honey supplementation could mitigate oxidative stress and inflammation in seminal plasma caused by intensive cycling training in male road cyclists.", "results_summary": "Honey supplementation significantly reduced inflammatory cytokines (IL-1\u03b2, IL-6, IL-8, TNF-\u03b1) and oxidative stress markers (ROS, MDA) while increasing antioxidant levels (SOD, catalase, TAC) compared to the control group receiving an artificial sweetener.", "population_specificity": "Healthy nonprofessional male road cyclists aged 18-28 years.", "effective_dosage": "70 g of honey consumed 90 minutes before each training session.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:14.859928+00:00"}
{"study_id": 17086, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic effects and underlying mechanisms of hordenine in treating ulcerative colitis (UC) using a mouse model.", "results_summary": "Hordenine significantly reduced disease activity, pro-inflammatory factors, and colonic lesions while improving intestinal barrier function and promoting mucosal healing, likely through inhibition of the SPHK-1/S1PR1/STAT3 signaling pathway.", "population_specificity": "DSS-induced ulcerative colitis mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:14.938172+00:00"}
{"study_id": 17087, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore Hordenine's effects on neuroinflammation and its specific mechanism in the context of Parkinson's disease.", "results_summary": "Hordenine reduced microglia activation in the substantia nigra compacta, protected dopaminergic neurons, and improved movement disorders and weight loss in a PD rat model. It also inhibited LPS-induced inflammatory responses in BV-2 cells, likely via NF-\u03baB and MAPK pathways.", "population_specificity": "6-OHDA-induced Parkinson's disease rat model and BV-2 microglial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:16.134321+00:00"}
{"study_id": 17089, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the effect and mechanism of hordenine on prolactinomas in rats, specifically its ability to reduce prolactin accumulation and inhibit the MAPK signaling pathway.", "results_summary": "Hordenine restored estradiol-induced pituitary overgrowth, reduced prolactin accumulation in serum and pituitary glands, and blocked MAPK pathway activation and inflammatory cytokine production (TNF-\u03b1, IL-1\u03b2, IL-6). Its antiprolactinoma effect was mediated by inhibiting MAPK signaling.", "population_specificity": "Rats with estradiol-induced prolactinomas.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:21.911852+00:00"}
{"study_id": 17090, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of hordenine on quorum sensing inhibition and metabolic changes in Pseudomonas aeruginosa PAO1.", "results_summary": "Hordenine exhibited potent quorum sensing inhibitory activity, disrupting the QS system, repressing antioxidant enzyme synthesis, enhancing oxidative stress, altering membrane components, and disturbing energy, amino acid, and nucleotide metabolism, ultimately attenuating pathogenicity.", "population_specificity": "Pathogenic bacterium Pseudomonas aeruginosa PAO1.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:21.933866+00:00"}
{"study_id": 17091, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of hordenine on quorum sensing-mediated pathogenicity of Serratia marcescens NJ01 in tomato plants.", "results_summary": "Hordenine significantly inhibited acyl-homoserine lactone production and biofilm formation, enhanced susceptibility of biofilms to ciprofloxacin, and attenuated the pathogenicity of S. marcescens NJ01 in tomato plants. It also affected virulence factors, intracellular metabolites, and downregulated QS- and biofilm-related genes.", "population_specificity": "Serratia marcescens NJ01 (pathogenic bacterium) and tomato plants.", "effective_dosage": "25, 50, and 100 \u03bcg/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:23.274033+00:00"}
{"study_id": 17092, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate hordenine's effect on enhancing the susceptibility of aminoglycoside antibiotics against Pseudomonas aeruginosa biofilms and its potential as a quorum sensing inhibitor.", "results_summary": "Hordenine significantly enhanced the effectiveness of aminoglycoside antibiotics (tobramycin, gentamycin, and amikacin) against P. aeruginosa biofilm formation and disrupted preformed biofilms. Microscopic and mechanistic studies showed hordenine downregulated genes involved in quorum sensing and biofilm formation.", "population_specificity": "Pseudomonas aeruginosa PAO1 biofilms (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:23.459939+00:00"}
{"study_id": 17088, "supplement_id": 1210, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate hordenine's binding affinity to PDK3, its inhibitory effects on PDK3 activity, and its cytotoxic effects on lung cancer cells while assessing its safety in non-cancerous cells.", "results_summary": "Hordenine showed excellent binding affinity to PDK3 (K = 106 M-1), inhibited PDK3 activity (IC50 = 5.4 \u00b5M), and demonstrated cytotoxic effects on lung cancer cells (A549 and H1299) without toxicity to non-cancerous HEK293 cells at concentrations up to 200 \u00b5M.", "population_specificity": "Human lung cancer cell lines (A549 and H1299) and non-cancerous HEK293 cells.", "effective_dosage": "IC50 values of 5.4 \u00b5M (PDK3 inhibition) and cytotoxic effects observed at unspecified concentrations (up to 200 \u00b5M for non-toxicity).", "study_duration": "Molecular dynamics simulation duration was 100ns; cell-based assay durations were not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:23.731896+00:00"}
{"study_id": 17093, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential anti-diabetic, anti-inflammatory, and anti-fibrotic effects of Hordenine (HOR) in combination with insulin in streptozotocin-induced diabetic mice.", "results_summary": "Combined HOR and insulin treatment significantly reduced blood glucose levels and improved renal function in diabetic mice. HOR also demonstrated anti-inflammatory, anti-fibrotic, and antioxidant effects, particularly in synergy with insulin, though it did not protect pancreatic structure or function.", "population_specificity": "Streptozotocin-induced diabetic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with insulin noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:24.090269+00:00"}
{"study_id": 17094, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate hordenine's quorum sensing inhibitory activity against Pseudomonas aeruginosa and its potential as a novel agent to combat foodborne pathogens.", "results_summary": "Hordenine inhibited acyl-homoserine lactone levels, reduced biofilm formation, disrupted preformed biofilms, and suppressed QS-related gene expressions and virulence factors in P. aeruginosa PAO1.", "population_specificity": "In vitro study on Pseudomonas aeruginosa PAO1 (bacterial strain).", "effective_dosage": "0.5 to 1.0 mg mL-1", "study_duration": "Not specified", "interactions": "Enhanced susceptibility with netilmicin (antibiotic) noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:24.795989+00:00"}
{"study_id": 17095, "supplement_id": 1210, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antibiofilm activity of hordenine (HD) and hordenine-fabricated gold nanoparticles (HD-AuNPs) against Pseudomonas aeruginosa.", "results_summary": "HD and HD-AuNPs exhibited significant antibiofilm activity, with HD-AuNPs showing greater inhibition (73.69\u201378.41%) and reducing exopolysaccharide production by 68.46%. Microscopy confirmed disruption of biofilm architecture.", "population_specificity": "Pseudomonas aeruginosa PAO1 (bacterial pathogen model).", "effective_dosage": "Not specified.", "study_duration": "12 hours (incubation time for nanoparticle synthesis).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:24.963785+00:00"}
{"study_id": 67902, "supplement_id": 1211, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential therapeutic effects of icariin, a component of Horny Goat Weed, on various disorders, particularly its neuroprotective and anti-inflammatory properties.", "results_summary": "Icariin demonstrated anti-oxidative, anti-neuroinflammatory, and anti-apoptotic effects, with potential benefits in Alzheimer's disease, cerebral ischemia, depression, Parkinson's disease, and multiple sclerosis. It inhibited amyloid \u03b2 production and reduced neurotoxicity induced by hydrogen peroxide.", "population_specificity": "Animal models and cell cultures (microglia).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:30.600952+00:00"}
{"study_id": 17096, "supplement_id": 1210, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the toxicity of hordenine and its effects on forage quality using meadow voles as a model.", "results_summary": "Hordenine did not affect vole diet intake, weight gain, or mortality but caused kidney lesions and glycosuria in 62% of the animals. It was found to be less toxic than gramine on a molar equivalent basis.", "population_specificity": "Meadow voles (Microtus pennsylvanicus), 31 days old.", "effective_dosage": "0, 0.15, 0.31, or 0.62% of the diet.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:31.436896+00:00"}
{"study_id": 67904, "supplement_id": 1211, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to summarize the available data on ingredients in top-selling nutraceuticals for men's sexual health, including Horny Goat Weed, to provide clinical guidance for urologists.", "results_summary": "The study found that Horny Goat Weed is a common ingredient in men's sexual health supplements, but the available medical literature on its efficacy is generally of low quality. No specific outcomes or effects of Horny Goat Weed were detailed in the abstract.", "population_specificity": "Men seeking urologic evaluation for sexual health matters.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:31.673716+00:00"}
{"study_id": 67903, "supplement_id": 1211, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of icariin, the major active component of Horny Goat Weed, in preventing and treating osteoporosis in ovariectomized rats through a systematic review and meta-analysis.", "results_summary": "The study found that icariin significantly increased bone mineral density (femur and lumbar spine) and improved bone histomorphometric parameters (higher trabecular area and thickness, lower trabecular separation) in ovariectomized rats compared to controls. It also reduced bone turnover markers (serum alkaline phosphatase and osteocalcin).", "population_specificity": "Ovariectomized rats (a model for postmenopausal osteoporosis).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:32.874027+00:00"}
{"study_id": 67906, "supplement_id": 1211, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the ethnopharmacology, biological activities, and chemical compounds of Epimedium species, focusing on their efficacy in treating sexual dysfunction and osteoporosis.", "results_summary": "The study found that Epimedium and its active compounds exhibit wide pharmacological actions, including hormone regulation, anti-osteoporosis effects, and anti-depressant activities, with prenyl-flavonoids identified as major constituents. Modern pharmacology and clinical practice support its use in traditional Chinese medicine for various health benefits.", "population_specificity": "Not specified (general review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:33.010263+00:00"}
{"study_id": 67905, "supplement_id": 1211, "safety_score": "40", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the safety and public health concerns of sexual enhancement products, including Horny Goat Weed, available online.", "results_summary": "The study identified Horny Goat Weed as a common ingredient in sexual enhancement products and noted its association with adverse events, such as mood changes, anxiety, hallucinations, and addictive behaviors. However, the abstract does not provide specific efficacy data for Horny Goat Weed.", "population_specificity": "General online consumers of sexual enhancement products, including potential psychiatric disorder patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:33.278388+00:00"}
{"study_id": 18346, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to study the physico-functional, bioactive, microstructure, and thermal characteristics of breakfast cereals made with non-conventional seed flour, including Horse Chestnut.", "results_summary": "The study found that increasing feed moisture content improved bulk density, water absorption, phenolic content, and antioxidant activity while maintaining desirable expansion and color. Extrusion altered starch structure, reducing crystallinity and forming an amylose-lipid complex network.", "population_specificity": "Not specified (in vitro or food product study, not human subjects).", "effective_dosage": "Not specified (study focused on processing parameters, not dosage).", "study_duration": "Not specified (no intervention period mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:33.547313+00:00"}
{"study_id": 18347, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of cyantraniliprole as an insecticide against Cameraria ohridella, a pest affecting horse chestnut, and to study its translocation within the plant.", "results_summary": "All three modes of cyantraniliprole application were effective against Cameraria ohridella, with differences in the time of action but no significant variation in speed between doses. Acropetal translocation was more intense than basipetal, and increased photon emission indicated metabolic upregulation in translaminar and acropetal treatments.", "population_specificity": "Horse chestnut trees infested with Cameraria ohridella.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:33.873082+00:00"}
{"study_id": 18349, "supplement_id": 1212, "safety_score": "30", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to report a case of accidental horse chestnut ingestion and its adverse effects, emphasizing the need for clinical monitoring in such cases.", "results_summary": "A 46-year-old male experienced epigastric pain, nausea, sweating, elevated liver enzymes, and atrial fibrillation after consuming horse chestnut. Symptoms resolved with conservative treatment, and he was discharged without further complications.", "population_specificity": "46-year-old male with no prior unusual medical findings.", "effective_dosage": "Not specified", "study_duration": "Not specified (monitoring occurred over one day)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:39.474321+00:00"}
{"study_id": 18348, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize escin extracts from Horse Chestnut seeds, analyze their cytotoxicity, and determine the role of aglycone ester functions in their toxicity.", "results_summary": "The study identified a 13% weight content of escins in dry seeds, confirmed the importance of aglycone ester functions for toxicity, and demonstrated that cytotoxicity depends on the ester functions' position.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:39.614871+00:00"}
{"study_id": 18350, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate a fast and efficient UHPLC-PDA method for quantifying polyphenols in Horse Chestnut bark to assess its quality and applicability for vascular ailment treatments.", "results_summary": "The study successfully optimized a chromatographic method for quantifying six primary coumarins and flavan-3-ols in Horse Chestnut bark, demonstrating good linearity, precision, accuracy, and sensitivity. The method was validated for real commercial samples and proved useful for quality control of herbal material.", "population_specificity": "Not specified (in vitro analysis of plant material).", "effective_dosage": "Not applicable (analytical method development).", "study_duration": "Not applicable (analytical method validation).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:41.256427+00:00"}
{"study_id": 18351, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Horse Chestnut extract (HCE) on MMP-1 and MMP-9 expressions during cutaneous wound healing in diabetic rats.", "results_summary": "HCE increased hydroxyproline levels, reduced MDA levels and MPO activity, and modulated MMP-1 and MMP-9 gene expressions, accelerating wound healing in diabetic rats. The extract demonstrated antioxidative and anti-inflammatory effects.", "population_specificity": "Diabetic rats with cutaneous wounds.", "effective_dosage": "Not specified.", "study_duration": "Measurements taken on the 3rd, 7th, and 14th days post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:41.312458+00:00"}
{"study_id": 18352, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of a chemical treatment on Horse Chestnut trees susceptible or resistant to the horse chestnut leafminer, focusing on soil nutrients, AM colonization, and root biomass.", "results_summary": "The study found higher carbon and nitrogen concentrations in leaves of treated trees, no significant difference in AM colonization between treated and untreated trees, and a tendency for higher fine root biomass under treated trees.", "population_specificity": "Mature A. hippocastanum trees (susceptible and resistant to C. ohridella).", "effective_dosage": "Not specified (one-time chemical preparation injected into tree trunks).", "study_duration": "7 years post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:41.932014+00:00"}
{"study_id": 18353, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether horse chestnut leaf extract (ALH-L1005) could inhibit matrix metalloproteinases (MMPs) and improve clinical outcomes in periodontitis.", "results_summary": "ALH-L1005 significantly improved clinical conditions and suppressed gelatinolytic and caseinolytic activities in periodontitis-induced beagles, comparable to the positive control (doxycycline). The results suggest it may effectively prevent and treat periodontitis by inhibiting MMP activity.", "population_specificity": "Beagles with induced periodontitis.", "effective_dosage": "100 mg/kg/day (low dose) and 200 mg/kg/day (high dose).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:42.201562+00:00"}
{"study_id": 18354, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of infrared and microwave radiation on the structural, physicochemical, and antioxidant properties of starch extracted from Indian Horse Chestnut.", "results_summary": "Radiation treatments increased water absorption capacity and light transmittance while decreasing amylose content, pH, and syneresis. The treatments also improved antioxidant activity and altered starch viscosity and gelatinization properties.", "population_specificity": "Not specified (in vitro study on starch properties)", "effective_dosage": "Not specified (radiation applied for 15 s, 30 s, and 45 s at a constant dose)", "study_duration": "Not specified (single treatment sessions)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:42.616211+00:00"}
{"study_id": 18355, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop embryogenic cultures of Horse Chestnut from stamen filaments and optimize procedures for somatic embryo development, maturation, and germination.", "results_summary": "Embryogenic tissues were successfully induced using Murashige and Skoog medium with 2,4-dichlorophenoxyacetic acid, and somatic embryos developed after transfer to hormone-free medium. Maturation and germination were achieved using polyethylene glycol 4000, activated charcoal, desiccation, and cold storage.", "population_specificity": "In vitro plant tissues (stamen filaments of Horse Chestnut)", "effective_dosage": "9.0 \u03bcM 2,4-dichlorophenoxyacetic acid (induction medium)", "study_duration": "8 weeks (cold storage phase)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:43.155599+00:00"}
{"study_id": 18356, "supplement_id": 1212, "safety_score": "30", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to report adverse effects and toxicity of intranasal snuff made from powdered horse chestnut seeds.", "results_summary": "A 15-year-old woman experienced vomiting, dyspnea, nasal irritation, and syncope after using horse chestnut snuff. Symptoms resolved within 2 days with supportive care, indicating self-limiting toxicity.", "population_specificity": "15-year-old female from the Kashubian region using horse chestnut snuff.", "effective_dosage": "Not specified (powdered seeds used as snuff).", "study_duration": "Single exposure (effects observed within 5-10 minutes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:48.416851+00:00"}
{"study_id": 18357, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to determine the effect of imidacloprid pesticide exposure on the digestive enzyme activity of Cameraria ohridella larvae feeding on chemically protected horse chestnut trees.", "results_summary": "The study found that pesticide exposure altered the digestive enzyme profile of larvae, with higher sucrase and lactase activities in treated groups compared to controls. Glycosidase activities showed similar patterns across generations in treated larvae, while proteolytic activity was higher in treated larvae with no inter-generation differences.", "population_specificity": "Cameraria ohridella larvae (L4 stage) feeding on white horse chestnut trees.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:48.486115+00:00"}
{"study_id": 18360, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of horse chestnut seed extract for chronic venous insufficiency.", "results_summary": "The abstract does not provide specific findings about the effects of horse chestnut seed extract, only describing the process of developing Summary of Findings tables.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:48.661437+00:00"}
{"study_id": 18358, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To review the efficacy and safety of oral horse chestnut seed extract (HCSE) versus placebo or reference therapy for the treatment of chronic venous insufficiency (CVI).", "results_summary": "HCSE showed significant improvement in CVI-related symptoms, particularly leg pain and leg volume reduction, compared to placebo. Adverse events were mild and infrequent, suggesting HCSE is a safe short-term treatment.", "population_specificity": "Individuals with chronic venous insufficiency (CVI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:49.330516+00:00"}
{"study_id": 18364, "supplement_id": 1212, "safety_score": "75", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical use of horse chestnut seed extract, particularly for chronic venous insufficiency.", "results_summary": "Horse chestnut seed extract appears beneficial for mild to moderate chronic venous insufficiency, with side effects similar to placebo. However, study limitations like inadequate randomization and short duration make definitive conclusions difficult.", "population_specificity": "Patients with mild to moderate chronic venous insufficiency.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "May interact with anticoagulants and antidiabetics.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:51.564294+00:00"}
{"study_id": 18359, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the histopathology of Pseudomonas syringae pv. aesculi infection in Horse Chestnut trees and explore heat-treatment as a method to eradicate the bacteria.", "results_summary": "The study found that Horse Chestnut trees respond to infection with cell wall lignification and suberin deposition, but these defenses are insufficient to stop bacterial spread. Heat-treatment at 39 \u00b0C was effective in controlling the infection in saplings.", "population_specificity": "Aesculus hippocastanum (Horse Chestnut) saplings infected with Pseudomonas syringae pv. aesculi.", "effective_dosage": "Not applicable (heat-treatment at 39 \u00b0C).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:51.713035+00:00"}
{"study_id": 18361, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the efficacy of Horse Chestnut extract in combination with prebiotics and flaxseed oil on selected parameters in rats with dimethylhydrazine-induced colon cancer.", "results_summary": "The combination of prebiotic with Horse Chestnut extract significantly decreased the activity of bacterial enzyme beta-glucuronidase but did not significantly reduce bile acids concentration. The study found that prebiotics alone and in combination with bioactive components like Horse Chestnut had protective effects against colon cancer.", "population_specificity": "Rats with dimethylhydrazine-induced colon cancer.", "effective_dosage": "Horse Chestnut extract at 1% of diet.", "study_duration": "Not specified (intervention followed two weeks after diet initiation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:51.720624+00:00"}
{"study_id": 18362, "supplement_id": 1212, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to raise awareness of potential anticoagulant effects of Horse Chestnut seed extract (HCSE) and its association with acute renal hemorrhage in patients with angiomyolipoma (AML).", "results_summary": "The study reported a life-threatening kidney rupture in a patient taking HCSE for venous insufficiency, highlighting HCSE's anticoagulant properties and its contraindication in patients with renal AML or those on other anticoagulants.", "population_specificity": "A patient with known renal angiomyolipoma (AML) taking HCSE for chronic venous insufficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Anticoagulants (relative contraindication mentioned)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:52.476878+00:00"}
{"study_id": 18365, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the influence of triazole derivatives on drought tolerance and post-drought recovery in horse chestnut saplings.", "results_summary": "Triazole derivatives (except myclobutanil) improved drought tolerance and recovery in horse chestnut saplings, enhancing physiological and biochemical parameters, reducing leaf necrosis, and increasing growth post-drought. The effects were most pronounced with epixiconazole and propiconazole, followed by penconazole and paclobutrazol, while myclobutanil showed no significant benefits.", "population_specificity": "Container-grown horse chestnut (Aesculus hippocastanum L.) saplings.", "effective_dosage": "Not specified", "study_duration": "3-week drought followed by 12-week recovery; 2-week drought followed by 12-week recovery in a separate study.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:57.632126+00:00"}
{"study_id": 18366, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-obesity effects of saponins from natural and processed edible Japanese horse chestnut seeds, focusing on their ability to inhibit pancreatic lipase and reduce fat absorption.", "results_summary": "The study found that saponin fractions from both natural and edible seeds inhibited pancreatic lipase in vitro and significantly reduced body weight, adipose tissue mass, and plasma triacylglycerol in mice fed high-fat diets over 8 weeks, without affecting food intake. The effects were attributed to inhibited fat digestion, evidenced by higher undigested fat content in feces.", "population_specificity": "Mice fed high-fat diets", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:57.639296+00:00"}
{"study_id": 18368, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify novel compounds derived from escins in edible horse chestnut seeds and evaluate their potential nutraceutical activities, particularly in attenuating blood glucose levels and inhibiting pancreatic lipase.", "results_summary": "The study found that deacetylescins (100 mg/kg) effectively attenuated blood glucose elevation in mice, with inhibitory effects following the order escins > deacetylescins > desacylescins. The compounds also inhibited pancreatic lipase, suggesting potential anti-obese effects.", "population_specificity": "Mice (oral glucose tolerance test)", "effective_dosage": "100 mg/kg (single oral administration)", "study_duration": "Single administration (acute effects)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:58.516503+00:00"}
{"study_id": 18367, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Horse Chestnut seed extract (HCSE) in treating chronic venous insufficiency and its associated symptoms.", "results_summary": "The study found that HCSE preparations (Aesculaforce) effectively reduced lower leg edema and alleviated symptoms like leg pain, heaviness, and itching in patients with chronic venous insufficiency and varicose veins. The treatment was reported as safe, well-tolerated, and acceptable to patients.", "population_specificity": "Patients with mild to moderate chronic venous insufficiency and varicose veins.", "effective_dosage": "Available as oral tincture, tablets (20 mg or 50 mg), and topical gel (specific dosing frequency not mentioned).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:58.606253+00:00"}
{"study_id": 18371, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To evaluate the efficacy and safety of oral horse chestnut seed extract (HCSE) compared to placebo or reference therapy for treating chronic venous insufficiency (CVI).", "results_summary": "HCSE significantly reduced leg pain and leg volume compared to placebo, with effects comparable to compression stockings in one trial. Adverse effects were mild and infrequent.", "population_specificity": "Patients with chronic venous insufficiency (CVI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:59.839207+00:00"}
{"study_id": 18370, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of oral horse chestnut seed extract (HCSE) compared to placebo or other treatments for chronic venous insufficiency (CVI).", "results_summary": "HCSE significantly reduced leg pain and leg volume compared to placebo, with effects comparable to compression stockings in one trial. Adverse events were mild and infrequent, suggesting HCSE is a safe short-term treatment for CVI.", "population_specificity": "Patients with chronic venous insufficiency (CVI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:00.549924+00:00"}
{"study_id": 18372, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of horse-chestnut seeds extract (HCSE) and compression therapy versus placebo in treating early and advanced chronic venous insufficiency (CVI).", "results_summary": "HCSE was found to be as effective as compression therapy in reducing lower leg volume (edema) in early CVI (Grade I), but less effective in advanced CVI (Grades II and IIIa). Compression therapy outperformed HCSE in advanced stages, though HCSE showed better results in Grade II than Grade IIIa.", "population_specificity": "Patients with early (Grade I) and advanced (Grades II and IIIa) chronic venous insufficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:02.682634+00:00"}
{"study_id": 18373, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To assess the evidence for or against horse-chestnut seed extract (HCSE) as a symptomatic treatment of chronic venous insufficiency (CVI).", "results_summary": "HCSE was found superior to placebo in reducing lower-leg volume, leg circumference, and symptoms like pain and fatigue. It was equally effective as reference medications and compression therapy, with mild and infrequent adverse effects.", "population_specificity": "Patients with chronic venous insufficiency (CVI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:04.688319+00:00"}
{"study_id": 18374, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness, tolerability, and safety of standardized horse chestnut extract in treating chronic venous insufficiency (CVI) symptoms.", "results_summary": "The study found that horse chestnut extract significantly improved or eliminated symptoms of CVI, including pain, tiredness, tension, swelling, itching, and edema tendency, with good tolerability and no major adverse reactions reported.", "population_specificity": "Over 5,000 patients with chronic venous insufficiency (CVI) treated by general practitioners.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:05.380573+00:00"}
{"study_id": 18376, "supplement_id": 1212, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy and safety of horse chestnut seed extract (HCSE) and compression stockings in reducing edema in patients with chronic venous insufficiency.", "results_summary": "HCSE significantly reduced lower leg volume (43.8 mL) and was statistically equivalent to compression therapy (46.7 mL), both outperforming placebo. Both treatments were well tolerated with no serious adverse events reported.", "population_specificity": "240 patients with chronic venous insufficiency.", "effective_dosage": "50 mg aescin, twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:06.797696+00:00"}
{"study_id": 17715, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review Huperzine A's neuroprotective properties, its therapeutic potential for neurodegenerative disorders, and biotechnological strategies for its production.", "results_summary": "The study found Huperzine A has significant neuroprotective effects, particularly in inhibiting acetylcholinesterase and modulating neurological pathways, with potential applications in Alzheimer's, Parkinson's, and other neurodegenerative diseases. It also highlighted biotechnological advancements to enhance production.", "population_specificity": "Not specified (review of in vitro, in vivo, and clinical data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:08.809583+00:00"}
{"study_id": 18375, "supplement_id": 1212, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of oxerutins (HR) and horse chestnut extract (HCE) for chronic venous insufficiency (CVI) and investigate the initial dose/maintenance dose concept for HR.", "results_summary": "HR (1000 mg/d) was equivalent or better than HCE (600 mg/d) in reducing leg volume, with a significant carry-over effect observed for both compounds. The maintenance dose of HR (500 mg/d) stabilized therapeutic benefits achieved under initial dose conditions.", "population_specificity": "137 postmenopausal female patients with CVI II.", "effective_dosage": "600 mg/d HCE, 1000 mg/d HR (initial dose), 500 mg/d HR (maintenance dose).", "study_duration": "4 weeks initial dose, 12 weeks maintenance dose, 6 weeks observation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:08.887351+00:00"}
{"study_id": 17716, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Huperzine A and its derivatives as treatments for Alzheimer's disease by assessing their acetylcholinesterase inhibitory activity and non-cholinergic effects in AD-mimicking models.", "results_summary": "Huperzine A and its derivatives showed lower anti-AChE activity than HupA but demonstrated significant protective effects against A\u03b225-35 cytotoxicity and arsenic-induced AD pathologies, including oxidative stress, neurite shortening, and protein dysregulation. Three compounds exhibited dual cholinergic and non-cholinergic functions, suggesting potential as alternative AD treatments.", "population_specificity": "Differentiated SH-SY5Y cells (in vitro AD-mimicking models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:10.392949+00:00"}
{"study_id": 17719, "supplement_id": 1213, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review structural modifications of Huperzine A over the past three decades to enhance its efficacy and therapeutic index.", "results_summary": "Huperzine A is a clinically approved acetylcholinesterase inhibitor for Alzheimer's disease but is associated with adverse effects like dizziness and nausea. Structural modifications have been explored to improve its efficacy and safety profile.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:12.693186+00:00"}
{"study_id": 17720, "supplement_id": 1213, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to develop a novel delivery system for Huperzine A using PBVHx microspheres to enhance its metabolic duration and efficacy in Alzheimer's disease therapy while reducing side effects.", "results_summary": "The study found that HupA-PBVHxMs extended Huperzine A's metabolic duration, improved AChE inhibition efficacy, reduced neurotoxicity, and enhanced cognitive function in AD mice, with sustained release for up to 40 days.", "population_specificity": "Alzheimer's disease model mice", "effective_dosage": "Not specified", "study_duration": "Over 20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:13.903690+00:00"}
{"study_id": 17717, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to establish growth kinetics and Huperzine A production in a new HupS21 cell line using flask and airlift bioreactor cultures.", "results_summary": "The airlift bioreactor outperformed flask cultures in cell growth, growth rate, doubling time, and Huperzine A production, with the alkaloidal extract showing 85.6% AChE inhibitory activity at 100 \u03bcg/mL.", "population_specificity": "In vitro cell line (HupS21) from Phlegmariurus taxifolius.", "effective_dosage": "Not specified for human use; extract tested at 100 \u03bcg/mL in AChE assay.", "study_duration": "60 days in flasks, 20 days in bioreactor.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:13.973683+00:00"}
{"study_id": 17721, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a sensitive and specific method for measuring Huperzine A in rat plasma and assess its pharmacokinetic properties.", "results_summary": "The study successfully developed a reliable method for quantifying Huperzine A in rat plasma, demonstrating excellent linearity, precision, and recovery. Huperzine A showed a long half-life and high oral bioavailability in rats.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:14.536617+00:00"}
{"study_id": 17722, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effects of Huperzine A on diabetic nephropathy and explore its underlying mechanisms.", "results_summary": "Huperzine A alleviated kidney injury in diabetic rats, regulated lipid metabolism, enriched microbial diversity, and improved microbiota imbalance. The effects were linked to Apoe and Apoc2 modulation, supported by transcriptomic, metabolomic, and microbiome analyses.", "population_specificity": "STZ-induced diabetic rats, diabetic patients, db/db mice, and cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:17.252313+00:00"}
{"study_id": 17723, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Huperzine A in reducing absence-like seizures in a rat model of genetic generalized epilepsy (GAERS).", "results_summary": "Huperzine A (3.0 mg/kg) significantly reduced seizures in the short term (30-60 min post-treatment) and over a 24-hour period, comparable to ethosuximide, with only mild, dose-dependent sedation reported.", "population_specificity": "Adult male Genetic Absence Epilepsy Rats from Strasbourg (GAERS).", "effective_dosage": "0.3, 1.0, and 3.0 mg/kg (single intraperitoneal dose, administered 7 days apart).", "study_duration": "Single-dose intervention with 24-hour EEG monitoring pre- and post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:19.176347+00:00"}
{"study_id": 17724, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the effect of Huperzine A on neurological deficits and related mechanisms in rats with spontaneous subarachnoid hemorrhage (SAH).", "results_summary": "Huperzine A improved neurological deficits, reduced nerve cell apoptosis, mitigated blood-brain barrier damage, and inhibited oxidative stress-mediated pyroptosis in SAH rats, partly through the NF-\u03baB pathway.", "population_specificity": "Rats with induced spontaneous subarachnoid hemorrhage (SAH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:19.520280+00:00"}
{"study_id": 17725, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Huperzine A injection (HAI) could treat Parkinson's disease (PD) in a murine model and identify its potential molecular mechanisms.", "results_summary": "HAI improved locomotor behaviors, learning and memory abilities, and prevented dopaminergic neuron degeneration in PD mice. It also restored disordered transcriptional levels of inflammatory and apoptosis-related genes and modulated inflammation and oxidative phosphorylation pathways.", "population_specificity": "MPTP-induced Parkinson's disease murine model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:20.876194+00:00"}
{"study_id": 17726, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Huperzine A could prevent retinal neurodegeneration in diabetic retinopathy and explore its potential mechanism.", "results_summary": "Huperzine A demonstrated a protective effect on the diabetic retina in a rat model, potentially acting through the key target HSP27 and apoptosis-related pathways by modulating HSP27 phosphorylation and activating antiapoptotic signaling.", "population_specificity": "Diabetic rat model induced by streptozotocin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:21.614597+00:00"}
{"study_id": 18369, "supplement_id": 1212, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of oral horse chestnut seed extract (HCSE) compared to placebo or reference therapy for treating chronic venous insufficiency (CVI).", "results_summary": "HCSE significantly reduced leg pain and leg volume compared to placebo, with effects comparable to compression stockings in one trial. Adverse events were mild and infrequent, suggesting HCSE is a safe short-term treatment for CVI.", "population_specificity": "Individuals with chronic venous insufficiency (CVI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:22.379927+00:00"}
{"study_id": 17728, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate Huperzine A's inhibitory potential against MARK4 and its implications for treating MARK4-directed diseases, including Alzheimer's disease.", "results_summary": "Huperzine A demonstrated significant inhibition of MARK4 (IC50 = 4.91 \u03bcM) and formed a stable complex with MARK4, suggesting its potential as a potent MARK4 inhibitor for treating related diseases.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:23.191179+00:00"}
{"study_id": 17727, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A (HupA) has neuroprotective effects and enhances neuronal regeneration in an optic nerve crush (ONC) model.", "results_summary": "Intravitreal injection of HupA promoted retinal ganglion cell (RGC) survival and axonal regeneration after ONC, mediated through the mTOR pathway, with effects blocked by rapamycin.", "population_specificity": "Optic nerve crush (ONC) model (animal study, not human).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:23.476361+00:00"}
{"study_id": 17729, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Huperzine A packaged with nanoliposomes (HuA-LIP) on neuronal damage induced by chronic intermittent hypoxia (CIH) in mice.", "results_summary": "HuA-LIP improved cognitive dysfunction and neuronal damage in CIH mice, reduced oxidative stress, lowered brain iron levels, and enhanced synaptic plasticity by activating the PKA\u03b1/Erk/CREB/BDNF pathway. HuA-LIP outperformed standard HuA in mitigating CIH-induced neuronal damage.", "population_specificity": "Mice exposed to chronic intermittent hypoxia (CIH).", "effective_dosage": "0.1 mg/kg, intraperitoneal injection.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:26.737149+00:00"}
{"study_id": 17731, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Huperzine A exerts disease-modifying effects in Alzheimer's disease by analyzing preclinical studies on rodent AD models.", "results_summary": "Huperzine A demonstrated AChE inhibition, enhanced ChAT activity, improved memory, and reduced A\u03b2 levels, suggesting disease-modifying potential. However, methodological quality varied, necessitating cautious interpretation and further replication.", "population_specificity": "Rodent models of Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:28.571366+00:00"}
{"study_id": 17730, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether continuous acetylcholinesterase inhibition via Huperzine A microspheres (HAM) could protect against myocardial damage in an isoprenaline-induced myocardial ischemia mice model.", "results_summary": "HAM treatment inhibited increases in cardiac injury markers (CK-MB, Tn-I), reduced heart tissue damage, lowered proinflammatory cytokines (TNF-\u03b1, IL-6), and suppressed JAK2/STAT3 signaling pathway activation. These protective effects were weakened by \u03b17nAChR antagonism.", "population_specificity": "Isoprenaline-induced myocardial ischemia mice model.", "effective_dosage": "Single dose of HAM (specific amount not stated).", "study_duration": "Effects observed for more than 7 days post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:29.397356+00:00"}
{"study_id": 17734, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the binding interaction between Huperzine A (HpzA) and human serum albumin (HSA) using computational and experimental methods.", "results_summary": "The study found that HpzA binds stably with HSA, as demonstrated by molecular docking, MD simulation, and fluorescence assays, suggesting potential implications for Alzheimer's disease therapy.", "population_specificity": "Not specified (in vitro and computational study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:29.599117+00:00"}
{"study_id": 17733, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the positive effects of Huperzine A and EGb 761\u00ae in patients with mild to moderate Alzheimer's disease over the past 10 years, focusing on their pharmacological functions in AD therapy.", "results_summary": "Huperzine A showed cholinergic and neuroprotective activities, improving cognition, daily living activities, and neuropsychiatric symptoms in AD patients. The study highlights its potential as a multifunctional molecule to slow AD progression.", "population_specificity": "Patients with mild to moderate Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:30.088171+00:00"}
{"study_id": 17732, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize current methods for Huperzine A production, including plant extraction, chemical synthesis, and biosynthesis advances, to provide insights for complete biosynthesis.", "results_summary": "The abstract highlights the limitations of current Huperzine A production methods (plant extraction) due to scarcity of Huperzia serrate and discusses emerging biosynthesis strategies, including synthetic pathways and key enzymes, but does not report clinical outcomes.", "population_specificity": "Not specified (review paper, not a clinical study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:30.779641+00:00"}
{"study_id": 17735, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the neuroprotective effects of Huperzine A in Alzheimer's disease and other pathologies, focusing on its cholinergic and non-cholinergic mechanisms.", "results_summary": "Huperzine A demonstrated significant neuroprotective properties in in vitro, in vivo, and human studies, with both cholinergic and non-cholinergic effects, though more evidence is needed for broader therapeutic implementation.", "population_specificity": "Not specified (includes in vitro, in vivo, and human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:31.191593+00:00"}
{"study_id": 17736, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective mechanism of Huperzine A (HupA) in a mouse model of traumatic brain injury (TBI), focusing on its antioxidative effects via the Nrf2-ARE pathway.", "results_summary": "HupA improved cognitive function, reduced brain edema, inhibited oxidative stress, and activated the Nrf2 pathway in TBI mice, suggesting neuroprotective benefits.", "population_specificity": "C57BL/6 mice with induced TBI.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:31.682464+00:00"}
{"study_id": 17738, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the clinical effect of huperzine A combined with hyperbaric oxygen on cognitive function and serum HIF-1\u03b1 levels in elderly patients with vascular dementia.", "results_summary": "The combination of huperzine A and hyperbaric oxygen significantly improved cognitive function (measured by HDS-R and MMSE scores) and serum markers (VEGF, Livin, HIF-1\u03b1) compared to huperzine A alone, with a higher disease control rate in the observation group.", "population_specificity": "Elderly patients with vascular dementia (n=120, aged not specified).", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:37.709857+00:00"}
{"study_id": 17739, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Huperzine A's potential as a treatment for glaucoma by assessing its ability to lower intraocular pressure (IOP) and provide retinal neuroprotection.", "results_summary": "Huperzine A lowered IOP via indirect M3 mAChR activation and provided neuroprotection against retinal damage through M1 mAChR/AKT/MAPK signaling, improving cell viability and reducing oxidative stress and apoptosis.", "population_specificity": "New Zealand rabbits (IOP) and rat retinas/primary retinal neurons (neuroprotection).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Atropine and pirenzepine reversed effects, indicating muscarinic receptor antagonist interactions.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:38.825605+00:00"}
{"study_id": 17745, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A could reduce heroin reward and heroin-seeking behavior in rats.", "results_summary": "Huperzine A dose-dependently suppressed cue- and heroin-induced reinstatement of heroin-seeking behavior but did not alter heroin's rewarding effects or spontaneous locomotion. The findings suggest Huperzine A may help prevent heroin relapse.", "population_specificity": "Rats trained to self-administer heroin", "effective_dosage": "0.05 to 0.2 mg/kg (acute treatment)", "study_duration": "Acute (single-dose) intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:40.020086+00:00"}
{"study_id": 17742, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to improve the yield of Huperzine A (HupA) from endophytic Alternaria brassicae AGF041 using UV and gamma radiation mutagenesis and to scale up production via batch fermentation.", "results_summary": "UV and gamma radiation significantly increased HupA yield (17.2% and 30.3%, respectively), while optimized compound irradiation resulted in a 53.1% production increase. Batch cultivation in a 6.6 L bioreactor successfully scaled up HupA production to 261.6 \u00b5g/L.", "population_specificity": "Not applicable (in vitro study using Alternaria brassicae AGF041 cultures).", "effective_dosage": "Not specified (study focused on production yield, not human dosage).", "study_duration": "Not specified (study focused on production methods, not intervention duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:40.731294+00:00"}
{"study_id": 17740, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to analyze the diversity of endophytic fungi in Huperzia serrata and their correlation with Huperzine A (HupA) production to identify strains capable of producing HupA more effectively.", "results_summary": "The study found that 11 endophytic fungal genera were positively correlated with HupA content, with Derxomyces showing the highest correlation. The HS7-1 strain was confirmed to produce HupA, with a total alkaloid concentration of 3.7 ug/g.", "population_specificity": "Not specified (study focused on plant and fungal samples, not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:41.986794+00:00"}
{"study_id": 17744, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a dissolving microneedle patch (DMNP) for transdermal delivery of Huperzine A (Hup A) in treating Alzheimer's disease (AD), comparing its pharmacokinetics and pharmacodynamics to oral administration.", "results_summary": "The DMNP showed sustained release of Hup A, with improved pharmacokinetic parameters (longer T max, t 1/2, and larger AUC) compared to oral administration. Cognitive function in AD rats significantly improved with both DMNP-Hup A and Oral-Hup A treatments.", "population_specificity": "AD-induced rats", "effective_dosage": "Same dose for both DMNP and oral groups (specific amount not stated)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:42.467363+00:00"}
{"study_id": 17743, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop a biosynthesis platform for Huperzine A using endophytic fungi from Huperzia serrata to address its scarcity for clinical treatment of Alzheimer's disease.", "results_summary": "The study identified five endophytic fungi capable of biosynthesizing Huperzine A, with one strain producing 112 times more than conventional fungi. The biosynthesized Huperzine A showed superior physicochemical properties, higher acetylcholinesterase inhibition, and lower cytotoxicity compared to existing APIs.", "population_specificity": "Not specified (in vitro study).", "effective_dosage": "319.8 \u00b1 0.17 mg/L (liquid culture).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:43.051747+00:00"}
{"study_id": 17746, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antioxidative and neuroprotective effects of Huperzine A (HupA) in combination with astaxanthin (AXT) against oxidative stress and neurotoxicity induced by TBHP or A\u03b225\u201135 in PC12 cells.", "results_summary": "Combining HupA with AXT significantly increased cell viability, reduced membrane damage, attenuated ROS formation, increased SOD activity, and decreased MDA levels compared to either drug alone. Pretreatment with HupA and AXT also decreased toxic damage from A\u03b225\u201135, suggesting enhanced neuroprotection.", "population_specificity": "PC12 cells (a rat adrenal pheochromocytoma cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:47.685141+00:00"}
{"study_id": 17749, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Huperzine A improves memory and learning in individuals with moderate-severe traumatic brain injury (TBI).", "results_summary": "The study found no difference in memory performance between Huperzine A and placebo groups after 12 weeks. Both groups showed clinically important improvements in depression, suggesting a placebo effect.", "population_specificity": "Individuals with moderate-severe traumatic brain injury (TBI).", "effective_dosage": "Not available", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:48.235141+00:00"}
{"study_id": 17747, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine how huperzine A and donepezil regulate neurogenic vasodilation in basilar arteries and their effects on nicotinic acetylcholine receptor subtypes.", "results_summary": "Huperzine A was 30-fold less potent than donepezil in inhibiting nicotine-induced vasodilation but similarly weak in reducing TNS-elicited nitrergic vasodilation. It also showed less inhibition of calcium influx and inward currents in nicotinic acetylcholine receptor-expressing cells compared to donepezil.", "population_specificity": "Isolated porcine basilar arteries and rodent superior cervical ganglionic neurons.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:48.394621+00:00"}
{"study_id": 17748, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to identify endophytic fungi capable of producing Huperzine A and confirm its production in a Fusarium isolate.", "results_summary": "The study identified a Fusarium isolate (C17) from Phlegmariurus taxifolius that produced 3.2 \u03bcg/g of Huperzine A in mycelial dry weight. The identification was confirmed through morphological and DNA-barcoding analysis.", "population_specificity": "Not applicable (in vitro study on fungal isolate).", "effective_dosage": "Not applicable (production yield: 3.2 \u03bcg/g in mycelial dry weight).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:49.136867+00:00"}
{"study_id": 17753, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify endophytic microorganisms capable of producing Huperzine A (HupA) and optimize its production for potential use in Alzheimer's disease treatment.", "results_summary": "The study identified Alternaria brassicae AGF041 as a promising strain for HupA production, achieving 75.5% acetylcholinesterase inhibition and maximizing HupA yield to 42.89 \u03bcg/g of dry mycelia after optimization. Statistical optimization increased production by 40.8%.", "population_specificity": "Endophytic fungal and actinobacterial isolates from Huperzia serrata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:52.064670+00:00"}
{"study_id": 17750, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a nasal temperature and pH dual-responsive in situ gel delivery system for Huperzine A to improve its brain bioavailability and evaluate its pharmacokinetic properties.", "results_summary": "The optimized nasal gel formulation achieved continuous and steady drug release, with brain-targeting properties comparable to intravenous administration, suggesting improved absorption and potential as a noninvasive alternative for Alzheimer's therapy.", "population_specificity": "Not specified (in vitro and in vivo pharmacokinetic studies, likely animal models).", "effective_dosage": "Not specified (optimized formulation composition provided: pluronic F127 20.80%, pluronic F68 2.8%, chitosan 0.88%).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:52.503209+00:00"}
{"study_id": 17752, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A improves metabolic and cognitive functions in high fat-induced obese mice and genetic ob/ob mice.", "results_summary": "Huperzine A (0.1 mg\u00b7kg-1\u00b7d-1) improved object recognition and spatial memory in HFD-fed mice but not in ob/ob mice. It also upregulated insulin and phosphorylated Akt levels in the cortex of HFD-fed mice and decreased cortical BACE1 expression at 0.3 mg\u00b7kg-1\u00b7d-1.", "population_specificity": "High fat-induced obese mice and genetic ob/ob mice.", "effective_dosage": "0.1 and 0.3 mg\u00b7kg-1\u00b7d-1, administered orally.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:53.429741+00:00"}
{"study_id": 17756, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A could protect against seizure severity and memory deficits in a kainic acid-induced temporal lobe epilepsy model in rats.", "results_summary": "Huperzine A significantly reduced seizure intensity, improved learning and memory, decreased oxidative stress and inflammation, and lowered acetylcholinesterase activity while increasing antioxidant enzyme activities.", "population_specificity": "Rats with kainic acid-induced temporal lobe epilepsy.", "effective_dosage": "0.1 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:56.007871+00:00"}
{"study_id": 17754, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A improves cognitive and task-switching abilities in patients with Alzheimer's Disease.", "results_summary": "Patients with AD showed significant cognitive and task-switching deficits compared to healthy individuals. After eight weeks of Huperzine-A treatment, these patients demonstrated notable improvements in cognition and task-switching abilities compared to baseline.", "population_specificity": "50 patients with Alzheimer's Disease and 50 healthy individuals from hospitals in Bahawalpur and Multan, Pakistan.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:56.104432+00:00"}
{"study_id": 17755, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to clarify the mechanism of Huperzine A biosynthesis in endophytic fungi and explore the role of epigenetic modifications in its production.", "results_summary": "The study identified key genes involved in Huperzine A biosynthesis in endophytic fungi, revealing differences from plant biosynthesis pathways. Epigenetic modifications, particularly histone methyltransferases and deacetylases, were found to regulate Huperzine A production.", "population_specificity": "Endophytic fungi (Penicillium polonicum hy4 and Colletotrichum gloeosporioides Cg01).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:57.036478+00:00"}
{"study_id": 17737, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the structure-activity relationship of C(2)-functionalized and O- or N-methyl-substituted huperzine A derivatives to enhance acetylcholinesterase inhibitory activity for Alzheimer's disease therapy.", "results_summary": "The study found that 2-methoxyhuperzine A exhibited moderate to high inhibitory potency against eeAChE (IC50 = 0.16 \u03bcM) with high selectivity over eqBChE (selectivity index = 3633). Computational analysis effectively guided the rational screening and design of promising drug candidates.", "population_specificity": "Not specified (in vitro and in silico study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:57.471181+00:00"}
{"study_id": 17757, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the phylogenetic relatedness of Huperzia species and investigate correlations between huperzine A content, morphotypes, and genotypes, particularly in Icelandic H. selago.", "results_summary": "The study found significant variation in huperzine A content among Icelandic H. selago genotypes, with genotype 3 showing comparable levels to Chinese H. serrata, a known source. Huperzine B content was much lower in Icelandic taxa compared to Chinese H. serrata.", "population_specificity": "Icelandic Huperzia selago taxa", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:57.984223+00:00"}
{"study_id": 17759, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A (HupA) could protect murine embryonic fibroblast NIH3T3 cells from X-ray radiation-induced damage and elucidate the underlying mechanisms.", "results_summary": "HupA significantly improved cell viability, reduced apoptosis, enhanced antioxidant enzyme activity, and mitigated oxidative stress in NIH3T3 cells after X-ray radiation. These effects were mediated through Nrf2/ARE signaling pathways involving AKT, p38, and ERK activation.", "population_specificity": "Murine embryonic fibroblast NIH3T3 cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:01.142470+00:00"}
{"study_id": 17758, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Huperzine A has an anti-aging effect in fatty liver cells and whether it suppresses hepatocyte senescence via the NF-\u03baB pathway.", "results_summary": "Huperzine A reduced markers of senescence, inflammation, oxidative stress, and apoptosis in fatty liver cells, suggesting an anti-aging effect mediated by the NF-\u03baB pathway.", "population_specificity": "L-02 fatty liver cells (in vitro model)", "effective_dosage": "0.1 \u03bcmol/L, 1.0 \u03bcmol/L, and 10 \u03bcmol/L", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:01.978459+00:00"}
{"study_id": 17760, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize the dissociation pathways of Huperzine A from acetylcholinesterase to understand its slow-onset inhibition mechanism, potentially aiding in the design of next-generation Alzheimer's disease treatments.", "results_summary": "The study identified two dissociation pathways for Huperzine A: a front door along the active-site gorge and a transient side door involving the \u03a9-loop. Both pathways showed similar dissociation rates, suggesting pathway hopping could occur under perturbations, providing insights for inhibitor design.", "population_specificity": "Torpedo californica acetylcholinesterase (in vitro study)", "effective_dosage": "Not specified", "study_duration": "4 \u03bcs molecular dynamics simulations", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:02.248695+00:00"}
{"study_id": 17762, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the neuroprotective effects of Huperzine A in traumatic brain injury (TBI) and its possible mechanisms.", "results_summary": "Huperzine A treatment improved Morris water maze performance, attenuated markers of neuroinflammation and oxidative stress, and promoted behavioral recovery in TBI mice.", "population_specificity": "Mice subjected to repetitive mild closed head injury (CHI) to mimic concussive TBI.", "effective_dosage": "1.0 mg/kg/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:05.165383+00:00"}
{"study_id": 17761, "supplement_id": 1213, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "To develop and evaluate mucoadhesive, lactoferrin-conjugated nanoparticles for intranasal delivery of Huperzine A to enhance brain targeting for Alzheimer's disease treatment.", "results_summary": "The optimized nanoparticles showed high drug entrapment, sustained release, enhanced cellular uptake, and improved brain targeting compared to non-targeted analogs, with lower cytotoxicity in cell lines.", "population_specificity": "In vitro (16HBE and SH-SY5Y cell lines) and in vivo (mouse models).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:06.148635+00:00"}
{"study_id": 17763, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Huperzine A's presence and anticholinesterase activity in three Huperzia species as potential sources for Alzheimer's disease treatment.", "results_summary": "The study found that H. dichotoma contains Huperzine A and exhibits strong anticholinesterase activity, while H. cuernavacensis and H. linifolia showed potential for other anticholinesterase compounds. The alkaloidal extracts of H. dichotoma and H. cuernavacensis demonstrated particularly low IC50 values, indicating high efficacy.", "population_specificity": "In vitro study (no human or animal subjects)", "effective_dosage": "Not specified (IC50 values provided for extracts)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:07.026442+00:00"}
{"study_id": 17764, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether Huperzine A (HupA) has antidepressant-like activity and improves neurological and cognitive functions in a rat model of post-stroke depression (PSD).", "results_summary": "HupA treatment for 4 weeks improved behavioral abnormalities, neurological and cognitive functions, and increased levels of neurotransmitters (NE, DA, 5-HT) and expression of key proteins (5-HT1AR, p-CREB, BDNF) in PSD rats. These findings suggest HupA has antidepressant-like effects and therapeutic potential for post-stroke depression.", "population_specificity": "Rats with induced post-stroke depression (PSD) via middle cerebral artery occlusion and chronic unpredictable mild stress.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:07.232878+00:00"}
{"study_id": 17765, "supplement_id": 1213, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Huperzine A could serve as an effective anticonvulsant for Alzheimer's disease patients, given its acetylcholinesterase-inhibiting properties and potential disease-modifying effects.", "results_summary": "The study hypothesized that Huperzine A may have a realistic role as an anticonvulsant in Alzheimer's disease, based on preclinical evidence suggesting its safety and efficacy. However, clinical outcomes were not explicitly detailed in the abstract.", "population_specificity": "Patients with Alzheimer's disease prone to seizures.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:07.300821+00:00"}
{"study_id": 17766, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of Huperzine A against iron overload-induced neuronal damage, focusing on oxidative stress, mitochondrial dysfunction, and iron metabolism.", "results_summary": "Huperzine A significantly protected neurons from iron overload-induced damage by reducing reactive oxygen species, increasing ATP levels, and normalizing iron metabolism, independent of its acetylcholinesterase-inhibiting effect.", "population_specificity": "Rat cortical neurons", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:09.191989+00:00"}
{"study_id": 17767, "supplement_id": 1213, "safety_score": "70", "efficacy_score": 60, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Huperzine A as an adjunctive treatment for major depressive disorder (MDD) through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found no significant improvement in depressive symptoms with adjunctive Huperzine A, but it did show greater cognitive functioning and quality-of-life improvements compared to antidepressant monotherapy. No significant difference in adverse drug reactions was observed between groups.", "population_specificity": "Patients with MDD aged 16-60 years in China.", "effective_dosage": "Not specified", "study_duration": "Average of 6.7 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:11.008085+00:00"}
{"study_id": 17768, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the molecular mechanisms by which Huperzine A (HupA) regulates the NF-\u03baB pathway in astrocytes to treat Alzheimer's disease (AD).", "results_summary": "HupA significantly down-regulated p65 expression in astrocytes induced by A\u03b2, suggesting it can regulate the NF-\u03baB pathway to treat AD. The study found that 10 \u03bcM A\u03b21-42 increased NF-\u03baB in astrocytes, and HupA counteracted this effect.", "population_specificity": "Astrocytes cultured in vitro (not human subjects).", "effective_dosage": "Different concentrations used (specific amounts not detailed in abstract).", "study_duration": "24 hours (acute treatment).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:11.426578+00:00"}
{"study_id": 17769, "supplement_id": 1213, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy of Huperzine A (HupA) in improving cognitive deficits in patients with schizophrenia spectrum disorders.", "results_summary": "HupA significantly improved cognitive function, as measured by various scales (Wechsler Memory Scale, Wechsler Adult Intelligence Scale, Wisconsin Card Sorting Test), and showed no significant difference in adverse events or discontinuation rates compared to controls.", "population_specificity": "Patients with schizophrenia spectrum disorders in China.", "effective_dosage": "Not specified", "study_duration": "11.7 \u00b1 6.0 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:13.819182+00:00"}
{"study_id": 17770, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop a population pharmacokinetic model of Huperzine A in elderly Chinese subjects to identify covariates affecting its pharmacokinetics for optimal individual administration.", "results_summary": "The study found that Huperzine A's plasma concentration-time profile was best described by a one-compartment model with first-order absorption and elimination, with age significantly influencing clearance. The final model was validated as suitable and effective.", "population_specificity": "Elderly Chinese healthy subjects and Alzheimer's disease patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:14.088008+00:00"}
{"study_id": 17771, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess Huperzine A's potential to protect neuronal mitochondria and reduce apoptosis following intracerebral hemorrhage in rats.", "results_summary": "Huperzine A reduced mitochondrial injury, decreased apoptosis, inhibited caspase-3 activation and cytochrome C translocation, and improved behavioral recovery in rats with induced brain hemorrhage.", "population_specificity": "Adult Sprague Dawley rats with induced intracerebral hemorrhage.", "effective_dosage": "Not specified", "study_duration": "Treatment administered immediately after ICH, with brains analyzed at 3, 6, 12, 24, or 48 hours post-ICH.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:15.037198+00:00"}
{"study_id": 17773, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the protective effects of Huperzine A against oxidative glutamate toxicity in mouse-derived hippocampal HT22 cells and explore its potential mechanisms.", "results_summary": "Huperzine A significantly protected HT22 cells from oxidative damage, suppressed ROS generation, and activated the BDNF/TrkB-dependent PI3K/Akt/mTOR signaling pathway, leading to reduced apoptosis.", "population_specificity": "Mouse-derived hippocampal HT22 cells", "effective_dosage": "10 \u03bcM for 24 hours", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:15.175334+00:00"}
{"study_id": 17772, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A reduces apoptotic cells and improves neurological function in rats with spinal cord injury.", "results_summary": "Huperzine A significantly reduced apoptotic cells and improved motor performance in rats with spinal cord injury, as evidenced by histopathological evaluations and BBB scores. The treatment group showed fewer necrotic cells and better locomotor abilities compared to controls.", "population_specificity": "Male Wistar Albino rats (220-340 g body weight) with induced spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Administered until 3rd and 7th days post-injury before perfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:15.571025+00:00"}
{"study_id": 17774, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate Huperzine A's antiepileptic potential and its mechanism of action, particularly its effects on GABA-mediated intracortical inhibition.", "results_summary": "Huperzine A suppressed seizures and epileptic spikes on EEG, enhanced gamma frequency band power, and increased intracortical inhibition while blocking PTZ-induced cortical excitation. Its effects were centrally mediated and independent of muscarinic acetylcholine receptors.", "population_specificity": "Rats in a pentylenetetrazole (PTZ) acute seizure model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Atropine and PTZ were co-administered to test receptor dependence; pyridostigmine was used to assess peripheral effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:18.670374+00:00"}
{"study_id": 17775, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and potential efficacy of Huperzine A as a treatment for cocaine use disorder, specifically its ability to attenuate cocaine-induced effects.", "results_summary": "Huperzine A was safe and well-tolerated, with the 0.4 mg dose significantly reducing cocaine-induced subjective effects like \"High\" and \"Stimulated,\" though it did not alter cocaine pharmacokinetics.", "population_specificity": "Participants with cocaine use disorder (n=14-17 per group).", "effective_dosage": "0.4 mg or 0.8 mg.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:19.311753+00:00"}
{"study_id": 17776, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if H. serrata extract (containing huperzine A) could improve cognitive function in Alzheimer's disease models by inhibiting acetylcholinesterase.", "results_summary": "H. serrata extract (0.5% huperzine A) inhibited AChE but not BuChE and improved cognitive function in mice, suggesting potential benefits for dementia in Alzheimer's disease.", "population_specificity": "Mice (animal model)", "effective_dosage": "30 mg/kg/day (H. serrata extract), 10 mg/kg/day (donepezil)", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:21.401389+00:00"}
{"study_id": 17777, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Huperzine A's protective effects against oligomeric A\u03b2(42)-induced neurotoxicity are linked to reducing intracellular/mitochondrial A\u03b2 accumulation and improving mitochondrial dysfunction.", "results_summary": "Huperzine A significantly reduced intracellular A\u03b2(42) levels, improved neuronal viability, and rescued mitochondrial dysfunction (e.g., ATP reduction, ROS overproduction, and membrane potential depolarization) caused by oligomeric A\u03b2(42). It also decreased A\u03b2(42) levels in mitochondria-enriched fractions and reduced A\u03b2(42) colocalization with mitochondrial markers.", "population_specificity": "Neuronal cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:22.948860+00:00"}
{"study_id": 17780, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to identify an endophytic fungal strain capable of producing Huperzine A to address the shortage of natural sources.", "results_summary": "The study isolated and identified the fungal strain ES026 (Colletotrichum gloeosporioides) as a producer of Huperzine A, with a yield of 1 \u03bcg/g dried mycelium, suggesting potential for cultivation and biosynthesis research.", "population_specificity": "Not applicable (in vitro study on fungal strains).", "effective_dosage": "Not specified (yield reported as 1 \u03bcg/g dried mycelium).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:23.911341+00:00"}
{"study_id": 17778, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the biosynthesis of Huperzine A in the endophytic fungus Colletotrichum gloeosporioides ES026 and identify key genes involved in its production.", "results_summary": "The study identified a gene encoding copper amine oxidase (CAO) as potentially involved in Huperzine A biosynthesis, with its expression correlating with the quantity of Huperzine A extracted from the fungus. The findings suggest CAO plays a key role in regulating Huperzine A content in ES026.", "population_specificity": "Not applicable (in vitro study on fungal and plant samples)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:23.991908+00:00"}
{"study_id": 17779, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify alkaloid- and Huperzine A-producing fungi from Huperzia serrata and establish a screening model for HupA-producing endophytic fungal strains.", "results_summary": "The study identified Paecilomyces tenuis YS-13 as a HupA-producing endophyte, with a fermentation yield of 21.0 \u03bcg/L and an IC50 of 1.27 \u00b1 0.04 mg/mL for the crude extract. This is the first report of P. tenuis producing HupA.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not applicable (fermentation yield: 21.0 \u03bcg/L)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:24.544711+00:00"}
{"study_id": 17781, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A (HupA) could protect against hepatic ischemia-reperfusion (HI/R) injury in mice by examining its antioxidative, anti-inflammatory, and antiapoptotic effects.", "results_summary": "HupA treatment significantly reduced liver damage markers (ALT, AST), enhanced antioxidant activity (SOD, CAT, GSH), decreased oxidative stress (MDA), and lowered inflammatory cytokines (NF-\u03baB p65, TNF-\u03b1, IL-1\u03b2, IL-6) and apoptosis (caspase-3 activity) in HI/R-injured mice.", "population_specificity": "Mice subjected to hepatic ischemia-reperfusion injury.", "effective_dosage": "167 and 500 \u03bcg/kg, administered once via tail vein injection 5 minutes prior to HI/R.", "study_duration": "Single-dose intervention with effects measured after 6 hours of reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:26.555224+00:00"}
{"study_id": 17782, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A could attenuate hepatic ischemia-reperfusion injury in rats through its anti-oxidative and anti-apoptotic properties.", "results_summary": "Huperzine A treatment significantly reduced liver injury markers (ALT, AST), enhanced antioxidant activity (SOD, CAT, GSH), decreased oxidative stress (MDA), and modulated apoptosis-related proteins (Bcl-2, Bax, caspase-3), indicating protective effects against HI/R injury.", "population_specificity": "Wistar rats subjected to hepatic ischemia-reperfusion injury.", "effective_dosage": "167 and 500 \u00b5g/kg, administered once via tail vein injection.", "study_duration": "Single dose administered 5 minutes before HI/R induction, with effects assessed after 6 hours of reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:28.861613+00:00"}
{"study_id": 17783, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to enhance the production of Huperzine A (HupA) from the endophytic fungus Shiraia sp. Slf14 by using inducers like Huperzia serrata extracts, L-lysine, and acetic acid.", "results_summary": "The study found that adding trace amounts of HupA, HSE, and L-lysine improved HupA production in Shiraia sp. Slf14, reaching a maximum content of approximately 40 \u03bcg g(-1). The bioprocessing strategy may be applicable to other endophytic fungal systems for efficient metabolite production.", "population_specificity": "Endophytic fungus Shiraia sp. Slf14 (in vitro study)", "effective_dosage": "Trace amounts of HupA (exact dosage not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:29.607550+00:00"}
{"study_id": 17784, "supplement_id": 1213, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Huperzine A in patients with Alzheimer's disease (AD) and vascular dementia (VD) through a meta-analysis of placebo-controlled RCTs.", "results_summary": "Huperzine A significantly improved MMSE and ADL scores in AD and VD patients, with longer durations enhancing efficacy in AD. Adverse effects were generally mild to moderate and transient, with fewer side effects observed in VD patients compared to AD.", "population_specificity": "Patients with Alzheimer's disease (733 participants) and vascular dementia (92 participants).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:30.829398+00:00"}
{"study_id": 17785, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the neuroprotective mechanism of Huperzine A, particularly its role in brain iron regulation and its effects on amyloid and tau pathology in Alzheimer's disease.", "results_summary": "Huperzine A reduced amyloid levels, plaque formation, and hyperphosphorylated tau in AD mice, while increasing ADAM10 expression. These benefits were largely negated by a high iron diet, suggesting iron regulation as a key mechanism.", "population_specificity": "APPswe/PS1dE9 transgenic Alzheimer's disease mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "High iron diet reduced Huperzine A's beneficial effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:32.150241+00:00"}
{"study_id": 17786, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cardioprotective potential of Huperzine A in a rat model of acute myocardial infarction.", "results_summary": "Huperzine A significantly reduced infarct size, inhibited myocardial enzyme activities, decreased oxidative stress markers, and exhibited anti-apoptotic and anti-inflammatory effects in rats with acute myocardial infarction.", "population_specificity": "Rats with induced acute myocardial infarction.", "effective_dosage": "Various concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:32.153496+00:00"}
{"study_id": 17787, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the beneficial and harmful effects of Huperzine A for treating Alzheimer's disease.", "results_summary": "Huperzine A showed significant improvements in cognitive function, daily living activity, and global clinical assessment in Alzheimer's patients, though methodological quality of trials was poor. No severe adverse events were reported.", "population_specificity": "Participants with Alzheimer's disease (1823 individuals across 20 RCTs).", "effective_dosage": "Not specified", "study_duration": "Varied (6, 8, 12, and 16 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:33.700894+00:00"}
{"study_id": 17788, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of low-dose Huperzine A on inflammatory molecule expression in EAE and its potential therapeutic role in neuroinflammatory diseases.", "results_summary": "Huperzine A significantly suppressed CCL2, IL-6, TNF-alpha, and IL-1beta expression in EAE mice and inhibited CCL2 production in astrocytes, reducing inflammatory cell infiltration. The effect on CCL2 was PPARgamma-dependent and nicotine receptor-independent.", "population_specificity": "MOG35-55-induced EAE mice and primary cultured astrocytes.", "effective_dosage": "0.1 mg/kg\u00b7d\u22121 (intraperitoneal injection)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:33.822076+00:00"}
{"study_id": 17789, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the feasibility of using iontophoresis to deliver therapeutic amounts of Huperzine A across the skin for Alzheimer's disease treatment.", "results_summary": "Iontophoresis significantly increased Huperzine A transport across skin (up to 184-fold), with high delivery efficiency (46-81%). Therapeutic amounts were achievable, and in vivo input rates exceeded in vitro results.", "population_specificity": "Porcine and human skin in vitro; male Wistar rats in vivo.", "effective_dosage": "1, 2, and 4 mM HupA; current densities of 0.15, 0.3, and 0.5 mA \u00b7 cm(-2).", "study_duration": "5-6 hours (in vitro and in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:37.187614+00:00"}
{"study_id": 17791, "supplement_id": 1213, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacokinetics and tolerance of ZT-1, a novel analogue of huperzine A, in healthy Chinese subjects.", "results_summary": "ZT-1 was rapidly absorbed and converted into huperzine A, with dose-proportional increases in AUC and Cmax. No serious adverse events were observed, and steady-state levels were achieved within 2 days of multiple dosing.", "population_specificity": "Healthy Chinese volunteers", "effective_dosage": "Single doses of 0.5, 0.75, 1, 1.25, or 1.5 mg; multiple doses of 0.75 mg/day", "study_duration": "Single-dose study and 8 consecutive days for multiple-dose study", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:38.760332+00:00"}
{"study_id": 17790, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Huperzine A (HupA) has protective effects against neurotransmitter changes caused by acute organophosphate poisoning (isocarbophos and phoxim) in mice.", "results_summary": "HupA showed protective effects against glutamatergic system disorders caused by isocarbophos poisoning, significantly elevating Glu and reducing nNOS expression. However, it had no effect on neurotransmitter changes induced by phoxim poisoning.", "population_specificity": "KM male mice", "effective_dosage": "HupA administered 2h before poisoning (exact dosage not specified)", "study_duration": "24 hours after exposure", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:39.309685+00:00"}
{"study_id": 17792, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to optimize fermentation conditions for Huperzine A production from endophytic fungi to address sustainability challenges in its extraction from plants.", "results_summary": "Optimization of fermentation parameters increased Huperzine A yield by 25.58%, with ethanol treatment showing the highest yield increase (51.89%). Potato extracts supplemented with glucose or sucrose, but not maltose, facilitated production, while methanol and ethanol acted as strong inducers.", "population_specificity": "Endophytic Colletotrichum gloeosporioides ES026 fungi.", "effective_dosage": "0.5-2% ethanol concentration.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:40.914955+00:00"}
{"study_id": 17795, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to explore the feasibility of nanocarrier-based transdermal delivery of Huperzine A for treating Alzheimer's disease.", "results_summary": "The study found that Huperzine A-loaded microemulsion exhibited superior skin permeation compared to nanostructured lipid carriers and solid lipid nanoparticles. In vivo testing showed significant cognitive improvement in mice treated with nanocarrier-based formulations compared to controls.", "population_specificity": "Mice (scopolamine-induced amnesia model)", "effective_dosage": "Not specified", "study_duration": "48 hours (skin irritation testing); in vivo efficacy duration not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:42.210575+00:00"}
{"study_id": 17796, "supplement_id": 1213, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to observe the effects of huperzine A on gastrointestinal motility and acetylcholinesterase (AChE) activity in mice to understand its side-effect tolerance.", "results_summary": "A single dose of huperzine A significantly inhibited AChE activity and increased gastrointestinal motility, but these effects were not observed after multiple doses (7 or 28 doses), suggesting rapid tolerance to gastrointestinal side-effects.", "population_specificity": "Mice", "effective_dosage": "Single dose and multiple doses (one dose per day for 7 or 28 days)", "study_duration": "Up to 28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:43.617185+00:00"}
{"study_id": 17798, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 1, "quality_score": 20, "study_goal": "To assess the clinical efficacy and safety of huperzine A for treating patients with mild cognitive impairment (MCI).", "results_summary": "No eligible trials were identified, so no conclusions could be drawn about huperzine A's efficacy or safety for MCI. The authors concluded that randomized double-blind placebo-controlled trials are needed.", "population_specificity": "Patients with mild cognitive impairment (MCI).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:46.512275+00:00"}
{"study_id": 17797, "supplement_id": 1213, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Huperzine A could mitigate chronic neuropathic pain after spinal cord injury by targeting multiple pain-related pathways without causing drug tolerance or dependence.", "results_summary": "Huperzine A demonstrated significant analgesic effects in rats with spinal cord injury, reduced neural inflammation, preserved GluR2-containing AMPA receptors, and prevented Homer1a up-regulation, all without inducing drug tolerance. The effects were cholinergic-dependent.", "population_specificity": "Female Sprague-Dawley rats (200-235 g body weight) with moderate static compression of T10 spinal cord.", "effective_dosage": "Not specified (administered i.p. or intrathecally).", "study_duration": "Not specified (tested with repeated bolus i.p. and chronic intrathecal dosing).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:46.848719+00:00"}
{"study_id": 17799, "supplement_id": 1213, "safety_score": "65", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a combination of [+]-Hup A and [-]-Hup A provides better protection against nerve agent toxicity compared to [+]-Hup A alone.", "results_summary": "The combination of [+]-Hup A and [-]-Hup A significantly increased survival rates, reduced behavioral abnormalities, and inhibited seizure-related EEG changes in guinea pigs exposed to soman, outperforming [+]-Hup A alone.", "population_specificity": "Guinea pigs exposed to soman toxicity.", "effective_dosage": "Not specified (small dose of [-]-Hup A combined with [+]-Hup A).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:48.332317+00:00"}
{"study_id": 17800, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to discuss the current progress and future perspective of Huperzine A therapy in Alzheimer's disease, including its mechanisms of action and efforts to optimize drug delivery.", "results_summary": "Huperzine A is a potent, selective, and reversible acetylcholinesterase inhibitor with multifaceted neuroprotective effects, including activation of the cholinergic system and direct action on mitochondria. Efforts to optimize drug delivery systems have been made to maximize its efficacy and safety.", "population_specificity": "Patients with Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:49.425401+00:00"}
{"study_id": 17801, "supplement_id": 1213, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cognitive-enhancing properties and neurochemical effects of huperzine A in triple transgenic mice (3xTg-AD) as a potential treatment for Alzheimer's disease.", "results_summary": "Huperzine A improved learning and memory in the Morris water maze, modulated emotional indicators, and activated neurochemical pathways related to Alzheimer's disease without significant adverse effects.", "population_specificity": "Seven-month-old homozygous 3xTg-AD male mice.", "effective_dosage": "0.8 \u00b5mol\u00b7kg(-1) administered intraperitoneally.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:51.936911+00:00"}
{"study_id": 17802, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Huperzine A has neuroprotective effects on mitochondrial dysfunction and memory deficits in Alzheimer's disease models, independent of its known AChE inhibitory action.", "results_summary": "Huperzine A improved mitochondrial dysfunction and memory deficits in A\u03b2PP/PS1 transgenic mice without inhibiting AChE. It also ameliorated A\u03b21-42-induced mitochondrial damage, including ATP reduction and respiratory chain complex dysfunction, likely by preventing A\u03b21-42 penetration into mitochondria.", "population_specificity": "A\u03b2PP/PS1 double transgenic mice (Alzheimer's disease model) and isolated brain cortical mitochondria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:52.465961+00:00"}
{"study_id": 17804, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the pharmacology and therapeutic potential of Huperzine A for treating neurodegenerative diseases, particularly Alzheimer's disease, and discuss synthetic studies to enable its pharmaceutical development.", "results_summary": "The abstract highlights Huperzine A's potent neuroprotective activities and its potential as a treatment for neurodegenerative diseases, but specific efficacy results are not detailed. Synthetic studies are mentioned to support its pharmaceutical development.", "population_specificity": "Not specified (general focus on neurodegenerative diseases, including Alzheimer's disease).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:54.971137+00:00"}
{"study_id": 17805, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a microemulsion-based transdermal patch for delivering Huperzine A and ligustrazine phosphate to evaluate their combined anti-amnesic effects.", "results_summary": "The study found that the transdermal patch increased permeation rates of Huperzine A and ligustrazine phosphate, showing dose-dependent anti-amnesic effects in scopolamine-induced amnesia rats, with combination therapy outperforming monotherapy.", "population_specificity": "Scopolamine-induced amnesia rats", "effective_dosage": "Multiple doses (specific amounts not provided)", "study_duration": "9 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:56.868379+00:00"}
{"study_id": 17807, "supplement_id": 1213, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to test the efficacy and safety of Huperzine A in treating mild to moderate vascular dementia (VaD).", "results_summary": "Huperzine A significantly improved cognitive function (MMSE, CDR, and ADL scores) in patients with mild to moderate VaD after 12 weeks, with no serious adverse events reported. The placebo group showed no such improvements.", "population_specificity": "78 patients with mild to moderate vascular dementia.", "effective_dosage": "0.1-mg bid (twice daily).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:00.979305+00:00"}
{"study_id": 17808, "supplement_id": 1213, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess Huperzine A's chemistry, pharmacology, and clinical effectiveness as a potential treatment for Alzheimer's disease.", "results_summary": "Huperzine A showed cognitive enhancement at 0.4 mg in clinical trials, with improvements in memory function tests (MMSE, ADAS-COG). It was well tolerated at doses up to 0.4 mg for 24 weeks, though animal studies indicated mild to moderate cholinergic side effects.", "population_specificity": "Patients with Alzheimer's disease (specific demographics not detailed).", "effective_dosage": "0.2 mg and 0.4 mg (only 0.4 mg showed efficacy).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:01.540653+00:00"}
{"study_id": 17806, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the neuroprotective effects of Huperzine A on synaptic deficits and its potential mechanisms in APPswe/PS1dE9 transgenic mice, focusing on amyloidogenic and nonamyloidogenic APP processing pathways.", "results_summary": "Chronic Huperzine A treatment significantly improved dendritic spine density and synaptotagmin levels, reduced amyloid plaque burden and oligomeric A\u03b2 levels, and modulated ADAM10 and BACE1 expression in APPswe/PS1dE9 mice, suggesting neuroprotective effects via APP processing regulation.", "population_specificity": "APPswe/PS1dE9 transgenic mice (a model for Alzheimer's disease).", "effective_dosage": "Not specified", "study_duration": "Chronic treatment (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:01.693612+00:00"}
{"study_id": 17809, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety, tolerability, and efficacy of Huperzine A in treating mild to moderate Alzheimer's disease, comparing two dosages to placebo.", "results_summary": "Huperzine A 200 \u03bcg BID showed no cognitive benefit, while 400 \u03bcg BID demonstrated a modest improvement in ADAS-Cog at 11 weeks but not at 16 weeks. No significant effects were observed on clinical global impression, neuropsychiatric symptoms, or daily living activities at either dose.", "population_specificity": "210 individuals with mild to moderate Alzheimer's disease.", "effective_dosage": "200 \u03bcg BID and 400 \u03bcg BID.", "study_duration": "At least 16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:04.110439+00:00"}
{"study_id": 17803, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A has immunomodulatory properties and potential therapeutic benefits in treating experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.", "results_summary": "Huperzine A significantly reduced neurological severity, decreased inflammatory cell accumulation, demyelination, and axonal injury in EAE mice, while modulating pro- and anti-inflammatory cytokine levels and inhibiting T-cell proliferation.", "population_specificity": "Murine model (mice with experimental autoimmune encephalomyelitis)", "effective_dosage": "Intraperitoneal injections (specific dosage not mentioned)", "study_duration": "Not specified", "interactions": "Mecamylamine (nicotinic acetylcholinergic receptor antagonist) reversed HupA's inhibition of T-cell proliferation.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:05.593504+00:00"}
{"study_id": 17810, "supplement_id": 1213, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate new mechanisms by which Huperzine A activates Wnt signaling and reduces amyloidosis in Alzheimer's disease (AD) brain.", "results_summary": "Huperzine A increased ADAM10, decreased BACE1 and APP695 protein levels, and reduced A\u03b2 levels and burden in mouse brain, suggesting enhanced nonamyloidogenic APP cleavage. It also inhibited GSK3\u03b1/\u03b2 activity and increased \u03b2-catenin levels, indicating neuroprotective effects via Wnt/\u03b2-catenin signaling.", "population_specificity": "\u03b2-amyloid (A\u03b2) precursor protein and presenilin-1 double-transgenic mice.", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:05.716137+00:00"}
{"study_id": 17811, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Huperzine A could enhance cognitive performance in normal young adult monkeys performing visual memory tasks of varying difficulty.", "results_summary": "Huperzine A did not significantly improve performance in monkeys performing optimally but showed improvement in poorly performing subjects (55-69% accuracy). It reduced accuracy when baseline performance was near maximum (90%).", "population_specificity": "Young adult pigtail macaques (Macaca nemestrina)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:08.662526+00:00"}
{"study_id": 17812, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the binding interactions of Huperzine A and galanthamine with the acetylcholinesterase enzyme to understand their inhibitory effects.", "results_summary": "Huperzine A showed stronger binding interactions with acetylcholinesterase than galanthamine, primarily due to hydrogen bond formation and hydrogen \u03c0 interactions with specific residues (Trp84 and Tyr130). The binding energy of Huperzine A was significantly higher (-28.4 kcal\u00b7mol(-1)) compared to galanthamine (-17.0 kcal\u00b7mol(-1)), suggesting more potent inhibition.", "population_specificity": "Not specified (in silico study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.860549+00:00"}
{"study_id": 17813, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if coadministration of Huperzine A and ligustrazine phosphate could improve memory deficits and reduce cholinergic impairment and oxidative stress in scopolamine-induced amnesia rats.", "results_summary": "Coadministration of Huperzine A and ligustrazine phosphate significantly reversed scopolamine-induced learning and memory impairment, inhibited acetylcholinesterase activity, increased antioxidant enzyme activities, and reduced lipid peroxidation. The results suggest potential benefits for preventing Alzheimer's disease.", "population_specificity": "Scopolamine-induced amnesia rats", "effective_dosage": "Huperzine A (0.14 mg/kg, i.g.) and ligustrazine phosphate (110 mg/kg, i.g.)", "study_duration": "10 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:11.095094+00:00"}
{"study_id": 17814, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to optimize the preparation and characteristics of Huperzine A-loaded nanostructured lipid carriers (NLC) for improved drug delivery in Alzheimer's disease treatment.", "results_summary": "The study successfully developed Huperzine A-loaded NLC with a mean particle size of 120 nm, high entrapment efficiency (89.18%), and controlled drug release over 96 hours. The formulation showed no recrystallization tendency and demonstrated potential for enhanced drug loading and prolonged release.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified (in vitro release study up to 96 hours)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.439387+00:00"}
{"study_id": 190118, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review newly proposed neuroprotective and anticonvulsant properties of Huperzine A based on animal studies.", "results_summary": "Huperzine A demonstrated neuroprotective effects by decreasing IL-1\u03b2 and TNF-\u03b1 protein expression, suppressing NF-\u03baB signaling, and increasing GABAergic transmission, which was associated with anticonvulsant activity.", "population_specificity": "Animal studies (specific species not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.691005+00:00"}
{"study_id": 17793, "supplement_id": 1213, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Huperzine A promotes hippocampal neurogenesis in vitro and in vivo, and its potential therapeutic role in neurological disorders.", "results_summary": "Huperzine A promoted proliferation of hippocampal neural stem cells in vitro and increased newly generated cells in the hippocampus of adult mice, mediated by the MAPK/ERK pathway. High concentrations reduced cell proliferation, while low concentrations enhanced it.", "population_specificity": "Mouse embryonic hippocampal neural stem cells (in vitro) and adult mice (in vivo).", "effective_dosage": "Not specified (low vs. high concentrations mentioned, but exact amounts not provided).", "study_duration": "4 weeks post-administration (in vivo).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:13.749086+00:00"}
{"study_id": 46426, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to compare the regenerative effects of hyaluronic acid (HA) with various by-products of human leukocyte platelet-rich fibrin (L-PRF) for interdental papillae reconstruction.", "results_summary": "HA was less effective than C-PRF in promoting fibroblast proliferation, vascularization, and epithelialization of the papillae. The study found no significant impact of HA on collagen density or interdental papilla height.", "population_specificity": "Sprague-Dawley rats with a modified open gingival embrasure (OGE) model.", "effective_dosage": "20 \u00b5L injected once.", "study_duration": "14 days (observations on days 7 and 14).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:14.306878+00:00"}
{"study_id": 46429, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and aesthetic outcomes of a non-surgical rhinoplasty algorithm using hyaluronic acid fillers for nasal profile correction.", "results_summary": "The study found that the 4-anatomic-point treatment algorithm significantly improved nasal profile and facial harmony, with high patient satisfaction and low morbidity. No major complications were reported, supporting its safety and effectiveness as a minimally invasive alternative to surgical rhinoplasty.", "population_specificity": "Patients undergoing primary or revision rhinoplasty.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:20.249167+00:00"}
{"study_id": 46430, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To compare the efficacy of two HA-based dermal fillers (CPM-HA20 and CPM-HA20G) in minimizing enlarged facial pores and improving skin quality.", "results_summary": "Both CPM-HA20 and CPM-HA20G reduced pore volume and improved skin hydration, with CPM-HA20G showing a 24.2% greater reduction in pore volume. Adverse events were mild and tolerable.", "population_specificity": "Thirty subjects with enlarged facial pores.", "effective_dosage": "1 mL per side for 3 sessions spaced 4 weeks apart.", "study_duration": "32 weeks (including follow-up).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:20.675906+00:00"}
{"study_id": 46427, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a hyaluronic acid (HA)-tethered liposomal delivery system for doxorubicin (DOX) and evaluate its effectiveness in targeting breast cancer cells.", "results_summary": "The HA-tethered liposomal formulation (HA-DOX-TPGS-LIPO) showed sustained drug release, higher cytotoxicity, increased cellular uptake, and greater ROS generation in breast cancer cells compared to free DOX or non-HA liposomal formulations. It also minimized NF-\u03baB protein expression, suggesting enhanced apoptosis.", "population_specificity": "MDA-MB-231 and MCF-7 breast cancer cell lines (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "72 hours (release kinetics); cellular assays duration not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.560852+00:00"}
{"study_id": 46432, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether hyaluronic acid-based nanomotors (HA-NMs) could effectively bypass biological barriers and enhance antibiotic delivery against bacterial infections.", "results_summary": "HA-NMs loaded with chloramphenicol demonstrated superior antimicrobial activity against E. coli compared to reference nanomotors and effectively penetrated mucin barriers, reducing bacterial proliferation significantly more than free antibiotic.", "population_specificity": "In vitro model (E. coli and mucin barriers)", "effective_dosage": "Not specified", "study_duration": "24-hour evaluation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.843043+00:00"}
{"study_id": 46428, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess hyaluronic acid as a biomarker for hepatic fibrosis in patients with chronic hepatitis B.", "results_summary": "Hyaluronic acid levels were significantly higher in participants with hepatic fibrosis and showed a strong positive correlation with fibrosis severity. It demonstrated good sensitivity (81.6%) and specificity (85.5%) for detecting moderate to severe fibrosis, with an AUC of 0.930.", "population_specificity": "100 participants with HBV-induced chronic liver disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:23.404462+00:00"}
{"study_id": 46431, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of hyaluronic acid (HA) as an adjunct to scaling and root planing (SRP) in improving clinical outcomes for periodontitis management.", "results_summary": "HA supplementation showed moderate improvements in clinical parameters like probing depth, clinical attachment level, bleeding on probing, gingival index, and plaque index compared to SRP alone, though heterogeneity in HA concentrations and application methods limited definitive conclusions.", "population_specificity": "Patients with periodontitis.", "effective_dosage": "HA concentrations ranged from 0.2% to 1.4%, but specific dosage and frequency were not detailed.", "study_duration": "Follow-up durations varied from 1 week to 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:25.397602+00:00"}
{"study_id": 46433, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify safety considerations and improve injection techniques for hyaluronic acid fillers in the facial upper third (forehead and temporal region).", "results_summary": "The study found variations in injection techniques and sites for hyaluronic acid fillers in the facial upper third, highlighting the lack of standardized approaches and the need for further investigation to enhance safety and efficacy.", "population_specificity": "Individuals receiving hyaluronic acid filler injections in the facial upper third (forehead and temporal region).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:25.512368+00:00"}
{"study_id": 46434, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "To investigate whether combining intra-articular hyaluronic acid injections with occlusal splint therapy improves treatment outcomes for non-reducible anterior disc displacement of the temporomandibular joint (ADDWoR).", "results_summary": "The combination therapy significantly improved clinical efficacy, pain reduction, mandibular function, and aesthetic recovery compared to occlusal splint therapy alone, with no increase in adverse reactions.", "population_specificity": "62 patients with ADDWoR.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:27.587313+00:00"}
{"study_id": 46435, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of hyaluronic acid (HA) injections, acupotomy subcision (AS), and their combination in reducing horizontal neck wrinkles and improving skin rejuvenation.", "results_summary": "All treatment groups showed improvements in wrinkle reduction and skin rejuvenation, with the combined AS+HA group demonstrating significantly better results in skin elasticity, collagen levels, and participant satisfaction at the 6-month follow-up.", "population_specificity": "30 female participants with neck Allergan Transverse Neck Lines Scale (ATNLS) scores of 3-4.", "effective_dosage": "Not specified", "study_duration": "3 months (once a month)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:29.093107+00:00"}
{"study_id": 46437, "supplement_id": 1214, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to document a rare adverse effect (granulomatous osteitis) caused by intra-articular hyaluronic acid injections in a patient with severe knee osteoarthritis.", "results_summary": "The study reported a case of granulomatous osteitis in the proximal tibial epiphysis following hyaluronic acid injection, with microscopic evidence of a gel-like substance and giant cell reaction. No efficacy outcomes for hyaluronic acid were assessed.", "population_specificity": "A single patient with severe knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:29.476316+00:00"}
{"study_id": 46438, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial efficacy and tolerability of a novel ophthalmic solution containing cross-linked hyaluronic acid in combination with PHMB for preoperative prophylaxis and infection control.", "results_summary": "The solution demonstrated fungistatic effects against certain fungi and significant bactericidal activity, particularly against P. aeruginosa and E. coli, while also reducing conjunctival bacterial load in vivo. The combination with hyaluronic acid enhanced tolerability and extended antimicrobial action.", "population_specificity": "43 patients undergoing cataract surgery.", "effective_dosage": "Not specified.", "study_duration": "Three days preoperatively.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:31.485721+00:00"}
{"study_id": 46439, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to examine the biological mechanisms of intra-articular hyaluronic acid (IAHA) in osteoarthritis (OA) management, including its effects on synovial fluid, inflammation, cartilage preservation, oxidative stress, and pain pathways.", "results_summary": "IAHA improves synovial fluid lubrication, reduces proinflammatory cytokines, inhibits matrix metalloproteinases, scavenges reactive oxygen species, and modulates pain pathways. High-molecular-weight IAHA is more effective in advanced OA, while low-molecular-weight formulations may benefit early-stage disease.", "population_specificity": "Patients with osteoarthritis (OA).", "effective_dosage": "Not specified (varies by molecular weight).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:32.034783+00:00"}
{"study_id": 46440, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and optimal techniques for breast augmentation using Hyaluronic Acid (HA) fillers in young female patients.", "results_summary": "The study demonstrated that HA fillers were effective in achieving natural breast enhancement with high patient satisfaction and minimal complications. Ultrasound-guided techniques improved accuracy and reduced risks like vascular occlusion and filler migration.", "population_specificity": "Young female patients seeking breast augmentation.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:32.531502+00:00"}
{"study_id": 46441, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of using an interdental brush dipped in 0.2% hyaluronic acid (HA) gel on clinical periodontal parameters in patients with periodontitis.", "results_summary": "The study found that using an interdental brush dipped in 0.2% HA significantly reduced gingival bleeding (PBI) compared to a regular interdental brush at 1 and 3 months, though other periodontal parameters (PI, PD, GI, CAL) showed no significant difference between groups. Both methods improved clinical outcomes compared to baseline.", "population_specificity": "60 patients with stages II/III grades A/B periodontitis.", "effective_dosage": "0.2% HA gel applied via interdental brush (frequency not specified).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:34.428781+00:00"}
{"study_id": 46443, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of hyaluronic acid in skin aging and wound healing, and explore its latest applications in anti-aging and wound treatment.", "results_summary": "Hyaluronic acid maintains skin hydration, elasticity, and firmness, and its decline with age leads to drier, less elastic skin and wrinkles. It also plays a key role in wound healing, with applications in anti-aging formulations, nutricosmetics, microneedles, nanoparticles, fillers, and wound dressings.", "population_specificity": "Not specified (general discussion of HA's role in skin and wound healing).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:38.738308+00:00"}
{"study_id": 46444, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a hyaluronic acid double network hydrogel (DNH) to improve wound healing by addressing the limitations of existing hydrogel dressings, such as slow gelation time, weak mechanical performance, and fast degradation.", "results_summary": "The DNH demonstrated a short gelation time (25 s), strong mechanical properties (Young's modulus = 82 kPa), and maintained structural integrity after swelling. In vivo tests showed faster wound healing, enhanced blood vessel formation, and improved macrophage polarization compared to gauze-treated wounds.", "population_specificity": "Full-thickness wound models (in vivo study, specific population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:39.740892+00:00"}
{"study_id": 46447, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To compare the efficacy of hyaluronic acid (HA) and platelet-rich plasma (PRP) against corticosteroid injections for pain relief and range of motion improvement in patients with adhesive capsulitis.", "results_summary": "HA demonstrated significant long-term efficacy in pain reduction and functional improvement at 6 months, with better outcomes compared to corticosteroids in some measures, though substantial heterogeneity was noted.", "population_specificity": "Adult patients with adhesive capsulitis (frozen shoulder).", "effective_dosage": "Not specified", "study_duration": "Follow-up periods ranged up to 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:40.133053+00:00"}
{"study_id": 46445, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of hyaluronic acid-coated COF loaded with doxorubicin (HA@DOX-COF) in inducing pyroptosis and enhancing antitumor immunity in triple-negative breast cancer (TNBC).", "results_summary": "HA@DOX-COF activated pyroptosis via the caspase-3/GSDME pathway, induced an antitumor immune response, and improved the efficacy of immune checkpoint blockade (ICB) in a TNBC murine model. The combination of HA@DOX-COF and anti-PD-1 antibody significantly inhibited tumor progression.", "population_specificity": "Triple-negative breast cancer (TNBC) murine model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:40.264261+00:00"}
{"study_id": 46446, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To evaluate the efficacy and safety of a single injection session of cross-linked hyaluronic acid gel for vulvovaginal atrophy compared to placebo.", "results_summary": "The study found that hyaluronic acid significantly reduced the severity of the most bothersome symptom, dryness, and dyspareunia, and improved sexual function scores compared to placebo at 12 weeks. No significant differences were observed in itching/irritation, pain, or vaginal pH between groups, and the treatment was well tolerated.", "population_specificity": "Postmenopausal women with vulvovaginal atrophy.", "effective_dosage": "Single injection session (specific dosage not detailed in abstract).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:40.768976+00:00"}
{"study_id": 46448, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical efficacy and safety of botulinum toxin A combined with hyaluronic acid in improving facial pore enlargement in acne patients.", "results_summary": "The combination treatment significantly improved facial pore enlargement one month post-treatment, with sustained effects observed at four months compared to baseline. Both physician assessments and patient satisfaction indicated positive outcomes.", "population_specificity": "40 acne patients with enlarged pores.", "effective_dosage": "Not specified (non-cross-linked hyaluronic acid compound injected via mesotherapy with nine 32-gauge microneedles).", "study_duration": "Follow-up assessments at one and four months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:41.000914+00:00"}
{"study_id": 46449, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of a hyaluronic acid-based adhesive hydrogel (HCM patch) in promoting muscle regeneration in volumetric muscle loss (VML).", "results_summary": "The HCM patch hydrogel effectively stimulated satellite cells and supported muscle regeneration with functional restoration in animal models of VML, demonstrating stable physical support and muscle tissue-specific biochemical cues.", "population_specificity": "Animal models (specific species not mentioned) with volumetric muscle loss.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:41.909263+00:00"}
{"study_id": 46450, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a biocompatible, stimuli-responsive imaging and therapeutic delivery system using hyaluronic acid-based polymersomes for enhanced MRI contrast and controlled release in pathological environments.", "results_summary": "The study found that hyaluronic acid-based polymersomes exhibited enhanced T2-weighted MRI contrast (3-fold higher relaxivity than existing agents) and demonstrated acid- and enzyme-triggered degradation, enabling controlled release and measurable contrast changes in pathological environments. Preliminary in vivo and postmortem studies confirmed strong imaging performance, high biocompatibility, and targeted response to enzymatic, acidic microenvironments.", "population_specificity": "Not specified (preliminary in vivo and postmortem studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:47.576094+00:00"}
{"study_id": 46460, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of hyaluronic acid (HA) conjugated with doxorubicin (DOX) and gemcitabine (GEM) for immunomodulation and tumor growth control in glioblastoma (GBM).", "results_summary": "HA-DOX and HA-GEM conjugates demonstrated synergistic cytotoxic effects, maintained immunogenic cell death properties, and reverted the immunosuppressive tumor microenvironment in GBM models, leading to controlled tumor growth and increased survival in mice.", "population_specificity": "Orthotopic GL261 and SB28-GBM tumor-bearing mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:49.336440+00:00"}
{"study_id": 46452, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of acellular hyaluronic acid matrix scaffold, combined with BMAC and autologous bone graft, in treating osteochondral lesions of the talus (OLTs) by assessing biomechanical support and microenvironment optimization.", "results_summary": "Postoperative outcomes significantly improved, with higher FAOS and SF-36 scores and reduced VAS scores. Early full weight-bearing mobilization (4th week) and lower BMI were associated with better clinical and MRI outcomes at 24 months.", "population_specificity": "80 patients (81 ankles) with osteochondral lesions of the talus (OLTs), excluding those with prior ankle surgery, lateral instability surgery, malignancy, or metabolic bone disease.", "effective_dosage": "Not specified", "study_duration": "Minimum follow-up of two years postoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:49.861192+00:00"}
{"study_id": 46461, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of hyaluronic acid-modified single-walled carbon nanotubes (HA-SWCNTs) for targeted delivery of 17-Hydroxy-jolkinolide B (HJB) to enhance tumor targeting and therapeutic efficacy in breast cancer.", "results_summary": "HA-SWCNTs-HJB showed improved tumor targeting and cytotoxicity against 4 T1 cells, with a 4.23-fold increase in cellular uptake compared to passive targeting. In vivo, it enhanced tumor accumulation, inhibited tumor growth, and suppressed metastasis without noticeable side effects.", "population_specificity": "4 T1 breast cancer-bearing mice.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:51.221634+00:00"}
{"study_id": 46454, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of hyaluronic acid-coated nanomicelles for targeted delivery of capecitabine to improve permeability and reduce systemic toxicity in breast cancer therapy.", "results_summary": "The study found that HA-CAP-M significantly improved permeability and cytotoxicity compared to free CAP, demonstrated dose-dependent apoptosis in MCF-7 cells, and showed good stability and controlled drug release.", "population_specificity": "MCF-7 breast cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:51.426680+00:00"}
{"study_id": 46451, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the molecular mechanisms by which selenide-modified hyaluronic acid hydrogel (Se-HA gel) promotes scleral remodeling during the recovery phase of form-deprivation myopia (FDM).", "results_summary": "The study found that Se-HA gel significantly promoted fibroblast proliferation, inhibited apoptosis, and prevented transdifferentiation at 250 \u03bcg/mL, while a 200 mg/kg subtenon injection improved ocular biometric parameters in FDM mice. It also downregulated HIF-1\u03b1 expression and regulated inflammation-related genes, with HIF-1\u03b1 overexpression reversing these effects.", "population_specificity": "Form-deprivation myopia (FDM) mouse model", "effective_dosage": "250 \u03bcg/mL in vitro, 200 mg/kg subtenon injection in vivo", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:52.033448+00:00"}
{"study_id": 46462, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a hyaluronic acid (HA)-encapsulated nanocomposite (HMP) for synergistic tumor treatment via chemodynamic therapy (CDT), photothermal therapy (PTT), and immunotherapy.", "results_summary": "The HMP nanocomposites demonstrated enhanced photothermal conversion efficiency (35.46%), GSH depletion, and Mn2+-mediated hydroxyl radical generation for CDT. They also stimulated immune responses (HMGB-1 release, CRT protein generation) and effectively inhibited tumor growth in mice.", "population_specificity": "BALB/c tumor-bearing mice (in vivo) and 4T1 cells (in vitro).", "effective_dosage": "Low doses (specific amounts not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:56.374867+00:00"}
{"study_id": 46442, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to develop a hyaluronic acid-based nanoplatform (HCCD) for combined chemotherapy and photodynamic therapy to enhance tumor targeting and treatment efficacy.", "results_summary": "The HCCD nanoplatform demonstrated significant tumor size reduction (11-fold compared to control) and activated systemic immune response, suppressing distant tumor growth. The approach showed precise tumor localization and synergistic enhancement of anti-tumor efficacy.", "population_specificity": "Tumor cells (in vitro and in vivo models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:57.650169+00:00"}
{"study_id": 46463, "supplement_id": 1214, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining monopolar radiofrequency (RF) and targeted ultrasound (TUS) promotes facial rejuvenation by increasing hyaluronic acid (HA) production in human skin.", "results_summary": "The combination of RF + TUS significantly increased HA-stained area by 48.65% at 1 month and 67.69% at 3 months, with visible improvements in skin tightness and rhytid reduction. Stand-alone RF showed minimal HA increase (6.76-9.56%), and the control group exhibited no changes.", "population_specificity": "Seven subjects aged 51-64 years with BMI 21.1-29.8 kg/m\u00b2.", "effective_dosage": "Four 60-minute treatments delivered 7-14 days apart.", "study_duration": "3 months (with follow-up assessments).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:58.354244+00:00"}
{"study_id": 46455, "supplement_id": 1214, "safety_score": "70", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to raise awareness about late complications associated with HA filler injections and highlight proper management strategies.", "results_summary": "Delayed complications to HA fillers include erythema, edema, inflammation, nodules, and infections, presenting weeks to months post-injection. Ultrasound imaging aids in diagnosis and management, with treatments like hyaluronidase and corticosteroid injections being effective.", "population_specificity": "Patients experiencing delayed reactions to HA fillers (case series of three patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:58.696410+00:00"}
{"study_id": 46466, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of hyaluronic acid (HA) with irisin (IR) and platelet-rich plasma (PRP) in accelerating fracture healing in rats.", "results_summary": "HA showed some improvement in bone volume and fracture healing but was statistically less effective than IR and comparable to PRP. By Week 4, IR significantly outperformed HA in bone volume and maximum strength.", "population_specificity": "Male Wistar albino rats with closed femoral fractures.", "effective_dosage": "Not specified", "study_duration": "2 and 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:59.502531+00:00"}
{"study_id": 46467, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a hyaluronic acid-modified nanocatalyst (HPPCQ) to regulate macrophage polarization and autophagy levels for sustained rheumatoid arthritis remission.", "results_summary": "HPPCQ demonstrated efficient ROS scavenging, promoted M1-to-M2 macrophage repolarization, and protected M2 macrophages from ferroptosis, significantly reducing clinical scores and inflammation in a mouse model of arthritis.", "population_specificity": "Collagen-induced arthritis (CIA) mouse model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:00.035432+00:00"}
{"study_id": 46464, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a microneedle-dosage form of hyaluronic acid (cAT-MN) in treating corneal stroma disorders in dry eye disease (DED), particularly in cases where conventional artificial tears (cAT) showed limited efficacy.", "results_summary": "The study found that cAT-MN with one treatment was significantly more effective than cAT (administered 4 times/day) in reducing corneal stroma scarring and alleviating DED symptoms during the first 5 days of benzalkonium chloride (BAC) exposure. A higher concentration of HA (6%) in the microneedle form restored corneal damage to healthy levels by enhancing HA delivery and permeation.", "population_specificity": "Subjects with benzalkonium chloride (BAC)-induced corneal stroma scarring and dry eye disease (DED) symptoms.", "effective_dosage": "0.1% HA in cAT (4 times/day); HA(6%)-MN (single treatment).", "study_duration": "5-day and 10-day BAC exposure periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:00.653886+00:00"}
{"study_id": 46465, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of hyaluronic acid-based hydrogel microspheres loaded with zinc oxide nanoparticles for treating infectious bone defects by assessing antibacterial activity and osteogenic potential.", "results_summary": "The hydrogel microspheres demonstrated significant antibacterial activity against *Staphylococcus aureus*, enhanced release of antimicrobial peptides in acidic conditions, and promoted osteogenic differentiation of bone marrow stromal cells. In vivo tests showed bone regeneration, improved angiogenesis, and anti-inflammatory effects in a rat skull defect model.", "population_specificity": "Rat model (skull defect) and in vitro bone marrow stromal cells.", "effective_dosage": "6 wt% HAD, 3 wt% AOHA, 1% BOHA, 0.5% photoinitiator, 0.05% ZnO-NPs.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:01.812038+00:00"}
{"study_id": 46468, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to quantitatively evaluate the efficacy of hyaluronic acid (HA) for osteoarthritis (OA) and identify patient subgroups that would benefit most from HA treatment.", "results_summary": "The study found that HA interventions were statistically more effective than placebo, with the best efficacy observed when HA was combined with corticosteroids or platelet-rich plasma. Younger, overweight knee OA patients with more severe baseline symptoms and lower KL grade benefited the most.", "population_specificity": "24,101 participants with symptomatic or radiographic osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Effects plateaued at approximately 2 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:04.777889+00:00"}
{"study_id": 46471, "supplement_id": 1214, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to develop and evaluate a radiopaque hyaluronic acid hydrogel for monitoring retention and therapeutic efficacy in treating osteoarthritis.", "results_summary": "The study found that the iodine-labeled HA hydrogel enabled long-term tracking in mouse knees and attenuated OA progression, with HA-I disappearance rate predicting treatment response. The hydrogel's properties allowed personalized treatment based on retention and therapeutic effect.", "population_specificity": "Mouse model of osteoarthritis", "effective_dosage": "Not specified", "study_duration": "Up to 5 weeks post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:05.834446+00:00"}
{"study_id": 46469, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a hyaluronic acid-based microneedle system could effectively deliver Platycladus orientalis leaf extract into the dermis to promote hair growth in androgenic alopecia.", "results_summary": "The study found that the hyaluronic acid microneedles successfully delivered the extract into the dermis, improved the hair follicle cell proliferation environment by reducing oxidative stress, and activated the Wnt/\u03b2-catenin pathway to promote hair growth.", "population_specificity": "Individuals with androgenic alopecia (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:05.889176+00:00"}
{"study_id": 46472, "supplement_id": 1214, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to compare the regenerative effects of hyaluronic acid (HA) alone and in combination with Wharton's jelly-derived MSCs and exosomes for cartilage repair in a rat model.", "results_summary": "The study found that HA alone did not significantly enhance cartilage repair compared to MSCs or exosomes, and combining HA with MSCs or exosomes showed no additional benefit. Cartilage repair was most effective with MSCs or exosomes alone.", "population_specificity": "Adult rats with full-thickness cartilage defects in the trochlear grooves of both distal femurs.", "effective_dosage": "Not specified (three intra-articular injections at weekly intervals).", "study_duration": "6 weeks (2 weeks post-surgery + 3 weekly injections + 4 weeks post-final injection).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:07.854288+00:00"}
{"study_id": 70804, "supplement_id": 1234, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "To determine if vaginal cleansing with povidone-iodine before cesarean delivery reduces the risk of maternal infectious morbidities, such as endometritis and wound complications.", "results_summary": "Vaginal preparation with povidone-iodine significantly reduced post-cesarean endometritis, particularly in women with ruptured membranes, with no reported adverse effects.", "population_specificity": "Women undergoing cesarean delivery (1946 participants, 1766 analyzed).", "effective_dosage": "Not specified (povidone-iodine solution used for vaginal cleansing).", "study_duration": "Immediate preoperative application.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:15.643601+00:00"}
{"study_id": 70802, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to analyze the effect of radioactive iodine (RAI) treatment on survival in medullary thyroid carcinoma (MTC) patients.", "results_summary": "The study found no significant effects of RAI treatment on disease-free survival (DFS) or disease-specific survival (DSS) in MTC patients. The authors concluded that RAI has no place in the treatment of MTC.", "population_specificity": "293 MTC patients without distant metastases who underwent total thyroidectomy between 1980 and 2007 in eight Dutch University Medical Centers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:15.701618+00:00"}
{"study_id": 70805, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of iodine-impregnated adhesive drapes on surgical site infection rates compared to no drapes.", "results_summary": "The study found no significant effect of iodine-impregnated adhesive drapes on surgical site infection rates (RR 1.03, 95% CI 0.06 to 1.66, P = 0.89). Length of hospital stay was similar between groups.", "population_specificity": "Patients undergoing any type of surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:16.046543+00:00"}
{"study_id": 70803, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the use of iodized salt in the food industry globally and analyze its market context in Bangladesh and Pakistan to improve national universal salt iodization (USI) programs.", "results_summary": "The study found that iodized salt use in the food industry has shown impact in industrialized countries, and processed foods containing salt are increasingly available in rural Bangladesh and Pakistan. However, the actual impact on iodine intake remains unquantified, and further data are needed.", "population_specificity": "Rural populations in Bangladesh and Pakistan, with a focus on bakers, food wholesalers, retailers, and processed food consumers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:16.215067+00:00"}
{"study_id": 70799, "supplement_id": 1234, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of adjuvant iodine-125 brachytherapy on postoperative recurrence and overall survival in hepatocellular carcinoma (HCC) patients after curative resection.", "results_summary": "The study found that iodine-125 brachytherapy significantly prolonged time to recurrence (60.0 vs. 36.7 months in controls) and improved 1-, 3-, and 5-year overall survival rates compared to the control group, with manageable adverse events.", "population_specificity": "68 HCC patients who underwent curative hepatectomy.", "effective_dosage": "Not specified (iodine-125 seed implantation on resection surface).", "study_duration": "Follow-up lasted 7.7-106.4 months (median 47.6 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:16.271483+00:00"}
{"study_id": 70806, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the surgical completeness and safety of bilateral axillo-breast approach (BABA) robotic thyroidectomy (RoT) for thyroid diseases.", "results_summary": "The study found that BABA RoT is safe and effective, with low rates of postoperative complications (e.g., transient hypoparathyroidism in 39.1%, transient vocal cord palsy in 14.2%) and recurrence, and good surgical completeness indicated by low thyroglobulin levels.", "population_specificity": "Patients undergoing BABA robotic thyroidectomy (1026 cases, 968 malignant tumors, 58 benign thyroid diseases).", "effective_dosage": "Not applicable (surgical study).", "study_duration": "Median follow-up of 23 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:16.865570+00:00"}
{"study_id": 70801, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the feasibility and outcomes of two radioguided localization techniques (ROLL-(99m)Tc and (125)I seed) for breast-conserving surgery after neoadjuvant systemic treatment.", "results_summary": "Both techniques showed comparable results in terms of resected specimen weight, margin status, and need for additional surgery, with no significant differences. The study concluded that (125)I seed localization simplifies surgery scheduling and is preferred for breast-conserving surgery post-neoadjuvant treatment.", "population_specificity": "Patients with nonpalpable breast tumors treated with neoadjuvant systemic therapy (n=154: 83 for ROLL-(99m)Tc, 71 for (125)I seed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:17.196338+00:00"}
{"study_id": 70800, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a bovine pericardial matrix (BPM) in preventing Frey's syndrome after parotidectomy compared to the superficial musculoaponeurotic system (SMAS) flap.", "results_summary": "The study found that BPM was more effective than SMAS flap in preventing Frey's syndrome, with 0% of BPM patients testing positive via Minor's test compared to 10% in the SMAS group. Subjective symptoms were also lower in the BPM group (5%) versus the SMAS group (10%).", "population_specificity": "40 patients with benign parotid gland tumors (30 pleomorphic adenoma, 7 Warthin tumor, 3 basal cell adenoma).", "effective_dosage": "Not specified", "study_duration": "12-month follow-up with a 3-year overall follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:17.589929+00:00"}
{"study_id": 70809, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To evaluate the clinical utility of dual energy spectral CT (DEsCT) in staging and characterizing gastric cancers, particularly using iodine concentration measurements.", "results_summary": "The study found that monochromatic images from DEsCT improved N-staging accuracy, and normalized iodine concentration (nIC) values helped differentiate between differentiated and undifferentiated gastric carcinomas and between metastatic and non-metastatic lymph nodes.", "population_specificity": "96 patients suspected of gastric cancers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:23.204139+00:00"}
{"study_id": 70807, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers reviewed the potential of gadolinium oxide nanoparticles as multimodal imaging agents, drug carriers, and therapeutic agents, comparing their efficacy to commercial iodine compounds.", "results_summary": "The study found that gadolinium oxide nanoparticles are superior to iodine compounds as CT and ultrasound imaging contrast agents and thermal neutron capture therapeutic agents, with potential for enhanced diagnosis and therapy when conjugated with targeting agents.", "population_specificity": "Not specified (review of nanoparticle applications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:23.319901+00:00"}
{"study_id": 70808, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the contribution of preablation Iodine 131 scans with SPECT/CT to the staging of differentiated thyroid cancer.", "results_summary": "The study found that preablation scans detected regional metastases in 35% of patients and distant metastases in 8%, changing staging in 4% of younger and 25% of older patients. These findings suggest that preablation scans significantly contribute to accurate thyroid cancer staging.", "population_specificity": "320 post-total thyroidectomy patients (138 aged <45 years, 182 aged \u226545 years), including subgroups with T1a and T1b tumors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:24.309467+00:00"}
{"study_id": 70811, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dual-energy CT (DECT) iodine quantification could better predict therapeutic response and survival in advanced GIST patients treated with tyrosine-kinase inhibitors compared to established criteria.", "results_summary": "DECT criteria showed significantly longer progression-free survival for responders (9-29 months vs. 2-6 months for non-responders) and was the only method to predict overall survival at 6 months. The absence of progression was the most predictive biomarker, regardless of criteria.", "population_specificity": "Seventeen patients with advanced gastrointestinal stromal tumors (GIST) treated with tyrosine-kinase inhibitors.", "effective_dosage": "Not specified", "study_duration": "Assessments at 2 and 6 months after treatment initiation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:24.697250+00:00"}
